<!DOCTYPE html>

<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">

<head>
  <meta charset="utf-8"/>
  <meta name="viewport" content="width=device-width, initial-scale=1"/>
  <meta http-equiv="X-UA-Compatible" content="IE=Edge,chrome=1"/>
  <meta name="generator" content="distill" />

  <style type="text/css">
  /* Hide doc at startup (prevent jankiness while JS renders/transforms) */
  body {
    visibility: hidden;
  }
  </style>

 <!--radix_placeholder_import_source-->
 <!--/radix_placeholder_import_source-->

<style type="text/css">code{white-space: pre;}</style>
<style type="text/css" data-origin="pandoc">
pre > code.sourceCode { white-space: pre; position: relative; }
pre > code.sourceCode > span { display: inline-block; line-height: 1.25; }
pre > code.sourceCode > span:empty { height: 1.2em; }
.sourceCode { overflow: visible; }
code.sourceCode > span { color: inherit; text-decoration: inherit; }
div.sourceCode { margin: 1em 0; }
pre.sourceCode { margin: 0; }
@media screen {
div.sourceCode { overflow: auto; }
}
@media print {
pre > code.sourceCode { white-space: pre-wrap; }
pre > code.sourceCode > span { text-indent: -5em; padding-left: 5em; }
}
pre.numberSource code
  { counter-reset: source-line 0; }
pre.numberSource code > span
  { position: relative; left: -4em; counter-increment: source-line; }
pre.numberSource code > span > a:first-child::before
  { content: counter(source-line);
    position: relative; left: -1em; text-align: right; vertical-align: baseline;
    border: none; display: inline-block;
    -webkit-touch-callout: none; -webkit-user-select: none;
    -khtml-user-select: none; -moz-user-select: none;
    -ms-user-select: none; user-select: none;
    padding: 0 4px; width: 4em;
    color: #aaaaaa;
  }
pre.numberSource { margin-left: 3em; border-left: 1px solid #aaaaaa;  padding-left: 4px; }
div.sourceCode
  {   }
@media screen {
pre > code.sourceCode > span > a:first-child::before { text-decoration: underline; }
}
code span.al { color: #ad0000; } /* Alert */
code span.an { color: #5e5e5e; } /* Annotation */
code span.at { color: #20794d; } /* Attribute */
code span.bn { color: #ad0000; } /* BaseN */
code span.bu { } /* BuiltIn */
code span.cf { color: #007ba5; } /* ControlFlow */
code span.ch { color: #20794d; } /* Char */
code span.cn { color: #8f5902; } /* Constant */
code span.co { color: #5e5e5e; } /* Comment */
code span.cv { color: #5e5e5e; font-style: italic; } /* CommentVar */
code span.do { color: #5e5e5e; font-style: italic; } /* Documentation */
code span.dt { color: #ad0000; } /* DataType */
code span.dv { color: #ad0000; } /* DecVal */
code span.er { color: #ad0000; } /* Error */
code span.ex { } /* Extension */
code span.fl { color: #ad0000; } /* Float */
code span.fu { color: #4758ab; } /* Function */
code span.im { } /* Import */
code span.in { color: #5e5e5e; } /* Information */
code span.kw { color: #007ba5; } /* Keyword */
code span.op { color: #5e5e5e; } /* Operator */
code span.ot { color: #007ba5; } /* Other */
code span.pp { color: #ad0000; } /* Preprocessor */
code span.sc { color: #20794d; } /* SpecialChar */
code span.ss { color: #20794d; } /* SpecialString */
code span.st { color: #20794d; } /* String */
code span.va { color: #111111; } /* Variable */
code span.vs { color: #20794d; } /* VerbatimString */
code span.wa { color: #5e5e5e; font-style: italic; } /* Warning */
</style>

  <!--radix_placeholder_meta_tags-->
  <title>KYS study group: 2장 10절: 글루타메이트 가설</title>

  <meta property="description" itemprop="description" content="Glutamate Hypothesis"/>



  <!--  https://developers.facebook.com/docs/sharing/webmasters#markup -->
  <meta property="og:title" content="KYS study group: 2장 10절: 글루타메이트 가설"/>
  <meta property="og:type" content="article"/>
  <meta property="og:description" content="Glutamate Hypothesis"/>
  <meta property="og:locale" content="en_US"/>
  <meta property="og:site_name" content="KYS study group"/>

  <!--  https://dev.twitter.com/cards/types/summary -->
  <meta property="twitter:card" content="summary"/>
  <meta property="twitter:title" content="KYS study group: 2장 10절: 글루타메이트 가설"/>
  <meta property="twitter:description" content="Glutamate Hypothesis"/>

  <!--/radix_placeholder_meta_tags-->
  
  <meta name="citation_reference" content="citation_title=Transition of Substance-Induced, brief, and atypical psychoses to schizophrenia: A systematic review and meta-analysis;citation_publication_date=2020;citation_volume=46;citation_doi=10.1093/schbul/sbz102;citation_issn=0586-7614, 1745-1701;citation_author=Benjamin Murrie;citation_author=Julia Lappin;citation_author=Matthew Large;citation_author=Grant Sara"/>
  <meta name="citation_reference" content="citation_title=Activation of 5-HT2A/C receptors counteracts 5-HT1A regulation of n-methyl-d-aspartate receptor channels in pyramidal neurons of prefrontal cortex;citation_publication_date=2008;citation_volume=283;citation_doi=10.1074/jbc.M801713200;citation_issn=0021-9258;citation_author=Eunice Y Yuen;citation_author=Qian Jiang;citation_author=Paul Chen;citation_author=Jian Feng;citation_author=Zhen Yan"/>
  <meta name="citation_reference" content="citation_title=Na-K-Cl cotransporter contributes to glutamate-mediated excitotoxicity;citation_publication_date=2003;citation_volume=23;citation_issn=0270-6474, 1529-2401;citation_author=Joe Beck;citation_author=Brett Lenart;citation_author=Douglas B Kintner;citation_author=Dandan Sun"/>
  <meta name="citation_reference" content="citation_title=The cognitive and negative symptoms in schizophrenia trial (CONSIST): The efficacy of glutamatergic agents for negative symptoms and cognitive impairments;citation_publication_date=2007;citation_volume=164;citation_doi=10.1176/appi.ajp.2007.06081358;citation_issn=0002-953X;citation_author=Robert W Buchanan;citation_author=Daniel C Javitt;citation_author=Stephen R Marder;citation_author=Nina R Schooler;citation_author=James M Gold;citation_author=Robert P McMahon;citation_author=Uriel Heresco-Levy;citation_author=William T Carpenter"/>
  <meta name="citation_reference" content="citation_title=Risk-Conferring glutamatergic genes and brain glutamate plus glutamine in schizophrenia;citation_publication_date=2017;citation_volume=8;citation_doi=10.3389/fpsyt.2017.00079;citation_issn=1664-0640;citation_author=Juan R Bustillo;citation_author=Veena Patel;citation_author=Thomas Jones;citation_author=Rex Jung;citation_author=Nattida Payaknait;citation_author=Clifford Qualls;citation_author=Jose M Canive;citation_author=Jingyu Liu;citation_author=Nora Irma Perrone-Bizzozero;citation_author=Vince D Calhoun;citation_author=Jessica A Turner;citation_author=Charles Gasparovic"/>
  <meta name="citation_reference" content="citation_title=The powerhouse takes control of the cell: Is the mitochondrial permeability transition a viable therapeutic target against neuronal dysfunction and death?;citation_publication_date=2005;citation_volume=38;citation_doi=10.1016/j.freeradbiomed.2004.11.032;citation_issn=0891-5849;citation_author=Irina G Stavrovskaya;citation_author=Bruce S Kristal"/>
  <meta name="citation_reference" content="citation_title=Negative schizophrenic symptomatology and the PCP (phencyclidine) model of schizophrenia;citation_publication_date=1987;citation_volume=9;citation_issn=0193-5216;citation_author=D C Javitt"/>
  <meta name="citation_reference" content="citation_title=Hippocampal glutamate and hippocampus subfield volumes in antipsychotic-naive first episode psychosis subjects and relationships to duration of untreated psychosis;citation_publication_date=2020;citation_volume=10;citation_doi=10.1038/s41398-020-0812-z;citation_issn=2158-3188;citation_author=Fr챕d챕ric Briend;citation_author=Eric A Nelson;citation_author=Omar Maximo;citation_author=William P Armstrong;citation_author=Nina V Kraguljac;citation_author=Adrienne C Lahti"/>
  <meta name="citation_reference" content="citation_title=Abnormal gamma oscillations in N-Methyl-D-Aspartate receptor hypofunction models of schizophrenia;citation_publication_date=2016;citation_volume=79;citation_doi=10.1016/j.biopsych.2015.07.005;citation_issn=0006-3223, 1873-2402;citation_author=Monika P Jadi;citation_author=M Margarita Behrens;citation_author=Terrence J Sejnowski"/>
  <meta name="citation_reference" content="citation_title=Evaluation of the efficacy, safety, and tolerability of BI 409306, a novel phosphodiesterase 9 inhibitor, in cognitive impairment in schizophrenia: A randomized, Double-Blind, Placebo-Controlled, phase II trial;citation_publication_date=2019;citation_volume=45;citation_doi=10.1093/schbul/sby049;citation_issn=0586-7614, 1745-1701;citation_author=David Brown;citation_author=Kazuyuki Nakagome;citation_author=Joachim Cordes;citation_author=Ronald Brenner;citation_author=Gerhard Gr체nder;citation_author=Richard S E Keefe;citation_author=Robert Riesenberg;citation_author=David P Walling;citation_author=Kristen Daniels;citation_author=Lara Wang;citation_author=Jennifer McGinniss;citation_author=Michael Sand"/>
  <meta name="citation_reference" content="citation_title=Glutamate: A neurotransmitter in mammalian brain;citation_publication_date=1984;citation_volume=42;citation_doi=10.1111/j.1471-4159.1984.tb09689.x;citation_issn=0022-3042;citation_author=F Fonnum"/>
  <meta name="citation_reference" content="citation_title=Gestational methylazoxymethanol acetate administration: A developmental disruption model of schizophrenia;citation_publication_date=2009;citation_volume=204;citation_doi=10.1016/j.bbr.2009.01.031;citation_issn=0166-4328, 1872-7549;citation_author=Daniel J Lodge;citation_author=Anthony A Grace"/>
  <meta name="citation_reference" content="citation_title=Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases;citation_publication_date=2009;citation_volume=30;citation_doi=10.1038/aps.2009.24;citation_issn=1671-4083, 1745-7254;citation_author=Xiao-Xia Dong;citation_author=Yan Wang;citation_author=Zheng-Hong Qin"/>
  <meta name="citation_reference" content="citation_title=Glutamatergic abnormalities in schizophrenia: A review of proton MRS findings;citation_publication_date=2014;citation_volume=152;citation_doi=10.1016/j.schres.2013.12.013;citation_issn=0920-9964, 1573-2509;citation_author=Eline M P Poels;citation_author=Lawrence S Kegeles;citation_author=Joshua T Kantrowitz;citation_author=Daniel C Javitt;citation_author=Jeffrey A Lieberman;citation_author=Anissa Abi-Dargham;citation_author=Ragy R Girgis"/>
  <meta name="citation_reference" content="citation_title=The effects of roflumilast, a phosphodiesterase type-4 inhibitor, on EEG biomarkers in schizophrenia: A randomised controlled trial;citation_publication_date=2021;citation_volume=35;citation_doi=10.1177/0269881120946300;citation_issn=0269-8811, 1461-7285;citation_author=James Gilleen;citation_author=Judith Nottage;citation_author=Farah Yakub;citation_author=Sarah Kerins;citation_author=Lorena Valdearenas;citation_author=Tolga Uz;citation_author=Gez Lahu;citation_author=Max Tsai;citation_author=Frank Ogrinc;citation_author=Steve C Williams;citation_author=Dominic Ffytche;citation_author=Mitul A Mehta;citation_author=Sukhi S Shergill"/>
  <meta name="citation_reference" content="citation_title=Effects of n-acetylcysteine on brain glutamate levels and resting perfusion in schizophrenia;citation_publication_date=2018;citation_volume=235;citation_doi=10.1007/s00213-018-4997-2;citation_issn=0033-3158, 1432-2072;citation_author=Grant McQueen;citation_author=John Lally;citation_author=Tracy Collier;citation_author=Fernando Zelaya;citation_author=David J Lythgoe;citation_author=Gareth J Barker;citation_author=James M Stone;citation_author=Philip McGuire;citation_author=James H MacCabe;citation_author=Alice Egerton"/>
  <meta name="citation_reference" content="citation_title=Juvenile treatment with mGluR2/3 agonist prevents schizophrenia-like phenotypes in adult by acting through GSK3棺;citation_publication_date=2018;citation_volume=137;citation_doi=10.1016/j.neuropharm.2018.05.019;citation_issn=0028-3908, 1873-7064;citation_author=Bo Xing;citation_author=Genie Han;citation_author=Min-Juan Wang;citation_author=Melissa A Snyder;citation_author=Wen-Jun Gao"/>
  <meta name="citation_reference" content="citation_title=Glutamate hypothesis in schizophrenia;citation_publication_date=2019;citation_volume=73;citation_doi=10.1111/pcn.12823;citation_issn=1323-1316, 1440-1819;citation_author=Yota Uno;citation_author=Joseph T Coyle"/>
  <meta name="citation_reference" content="citation_title=The mGluR2/3 agonist pomaglumetad methionil normalizes aberrant dopamine neuron activity via action in the ventral hippocampus;citation_publication_date=2020;citation_volume=45;citation_doi=10.1038/s41386-020-0764-2;citation_issn=0893-133X, 1740-634X;citation_author=Susan F Sonnenschein;citation_author=Anthony A Grace"/>
  <meta name="citation_reference" content="citation_title=Double-blind, placebo-controlled, crossover trial of glycine adjuvant therapy for treatment-resistant schizophrenia;citation_publication_date=1996;citation_volume=169;citation_doi=10.1192/bjp.169.5.610;citation_issn=0007-1250;citation_author=U Heresco-Levy;citation_author=D C Javitt;citation_author=M Ermilov;citation_author=C Mordel;citation_author=A Horowitz;citation_author=D Kelly"/>
  <meta name="citation_reference" content="citation_title=Effect of clozapine and adjunctive high-dose glycine in treatment-resistant schizophrenia;citation_publication_date=1999;citation_volume=156;citation_doi=10.1176/ajp.156.1.145;citation_issn=0002-953X;citation_author=S G Potkin;citation_author=Y Jin;citation_author=B G Bunney;citation_author=J Costa;citation_author=B Gulasekaram"/>
  <meta name="citation_reference" content="citation_title=Na(+)-K(+)-ATPase inhibition and depolarization induce glutamate release via reverse na(+)-dependent transport in spinal cord white matter;citation_publication_date=2001;citation_volume=107;citation_doi=10.1016/s0306-4522(01)00385-2;citation_issn=0306-4522;citation_author=S Li;citation_author=P K Stys"/>
  <meta name="citation_reference" content="citation_title=Amelioration of negative symptoms in schizophrenia by glycine;citation_publication_date=1994;citation_volume=151;citation_doi=10.1176/ajp.151.8.1234;citation_issn=0002-953X;citation_author=D C Javitt;citation_author=I Zylberman;citation_author=S R Zukin;citation_author=U Heresco-Levy;citation_author=J P Lindenmayer"/>
  <meta name="citation_reference" content="citation_title=PDE inhibitors for the treatment of schizophrenia;citation_publication_date=2017;citation_volume=17;citation_doi=10.1007/978-3-319-58811-7\_14;citation_issn=2190-5215;citation_author=Gretchen L Snyder;citation_author=Kimberly E Vanover"/>
  <meta name="citation_reference" content="citation_title=Meta-analysis of the efficacy of adjunctive NMDA receptor modulators in chronic schizophrenia;citation_publication_date=2011;citation_volume=25;citation_doi=10.2165/11586650-000000000-00000;citation_issn=1172-7047, 1179-1934;citation_author=Surendra P Singh;citation_author=Vidhi Singh"/>
  <meta name="citation_reference" content="citation_title=Memantine hydrochloride;citation_publication_date=2004;citation_volume=3;citation_doi=10.1038/nrd1311;citation_issn=1474-1776;citation_author=Andrea Witt;citation_author=Nancy Macdonald;citation_author=Peter Kirkpatrick"/>
  <meta name="citation_reference" content="citation_title=Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate;citation_publication_date=1969;citation_volume=164;citation_doi=10.1126/science.164.3880.719;citation_issn=0036-8075;citation_author=J W Olney"/>
  <meta name="citation_reference" content="citation_title=Nature of glutamate alterations in schizophrenia: A meta-analysis of proton magnetic resonance spectroscopy studies;citation_publication_date=2016;citation_volume=73;citation_doi=10.1001/jamapsychiatry.2016.0442;citation_issn=2168-622X, 2168-6238;citation_author=Kate Merritt;citation_author=Alice Egerton;citation_author=Matthew J Kempton;citation_author=Matthew J Taylor;citation_author=Philip K McGuire"/>
  <meta name="citation_reference" content="citation_title=Concept of excitotoxicity via glutamate receptors;citation_publication_date=2014;citation_publisher=Springer New York;citation_doi=10.1007/978-1-4614-5836-4\_125;citation_author=Juan C Pi챰a-Crespo;citation_author=Sara Sanz-Blasco;citation_author=Stuart A Lipton"/>
  <meta name="citation_reference" content="citation_title=Recent advances in the phencyclidine model of schizophrenia;citation_publication_date=1991;citation_volume=148;citation_doi=10.1176/ajp.148.10.1301;citation_issn=0002-953X;citation_author=D C Javitt;citation_author=S R Zukin"/>
  <meta name="citation_reference" content="citation_title=Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses;citation_publication_date=1994;citation_volume=51;citation_doi=10.1001/archpsyc.1994.03950030035004;citation_issn=0003-990X;citation_author=J H Krystal;citation_author=L P Karper;citation_author=J P Seibyl;citation_author=G K Freeman;citation_author=R Delaney;citation_author=J D Bremner;citation_author=G R Heninger;citation_author=M B Bowers;citation_author=D S Charney"/>
  <meta name="citation_reference" content="citation_title=Epigenetic mechanisms underlying NMDA receptor hypofunction in the prefrontal cortex of juvenile animals in the MAM model for schizophrenia;citation_publication_date=2017;citation_volume=143;citation_doi=10.1111/jnc.14101;citation_issn=0022-3042, 1471-4159;citation_author=Yelena Gulchina;citation_author=Song-Jun Xu;citation_author=Melissa A Snyder;citation_author=Felice Elefant;citation_author=Wen-Jun Gao"/>
  <meta name="citation_reference" content="citation_title=Subanesthetic doses of ketamine stimulate psychosis in schizophrenia;citation_publication_date=1995;citation_volume=13;citation_doi=10.1016/0893-133X(94)00131-I;citation_issn=0893-133X;citation_author=A C Lahti;citation_author=B Koffel;citation_author=D LaPorte;citation_author=C A Tamminga"/>
  <meta name="citation_reference" content="citation_title=Phosphodiesterase inhibition and modulation of corticostriatal and hippocampal circuits: Clinical overview and translational considerations;citation_publication_date=2018;citation_volume=87;citation_doi=10.1016/j.neubiorev.2018.02.007;citation_issn=0149-7634, 1873-7528;citation_author=P R A Heckman;citation_author=A Blokland;citation_author=E P P Bollen;citation_author=J Prickaerts"/>
  <meta name="citation_reference" content="citation_title=De novo mutations in schizophrenia implicate synaptic networks;citation_publication_date=2014;citation_volume=506;citation_doi=10.1038/nature12929;citation_issn=0028-0836, 1476-4687;citation_author=Menachem Fromer;citation_author=Andrew J Pocklington;citation_author=David H Kavanagh;citation_author=Hywel J Williams;citation_author=Sarah Dwyer;citation_author=Padhraig Gormley;citation_author=Lyudmila Georgieva;citation_author=Elliott Rees;citation_author=Priit Palta;citation_author=Douglas M Ruderfer;citation_author=Noa Carrera;citation_author=Isla Humphreys;citation_author=Jessica S Johnson;citation_author=Panos Roussos;citation_author=Douglas D Barker;citation_author=Eric Banks;citation_author=Vihra Milanova;citation_author=Seth G Grant;citation_author=Eilis Hannon;citation_author=Samuel A Rose;citation_author=Kimberly Chambert;citation_author=Milind Mahajan;citation_author=Edward M Scolnick;citation_author=Jennifer L Moran;citation_author=George Kirov;citation_author=Aarno Palotie;citation_author=Steven A McCarroll;citation_author=Peter Holmans;citation_author=Pamela Sklar;citation_author=Michael J Owen;citation_author=Shaun M Purcell;citation_author=Michael C O&lt;e2&gt;섵onovan"/>
  <meta name="citation_reference" content="citation_title=Positive allosteric modulators of metabotropic glutamate 2 receptors in schizophrenia treatment;citation_publication_date=2015;citation_volume=38;citation_doi=10.1016/j.tins.2015.06.002;citation_issn=0166-2236, 1878-108X;citation_author=Amr Ellaithy;citation_author=Jason Younkin;citation_author=Javier Gonz찼lez-Maeso;citation_author=Diomedes E Logothetis"/>
  <meta name="citation_reference" content="citation_title=Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia;citation_publication_date=1980;citation_volume=20;citation_doi=10.1016/0304-3940(80)90178-0;citation_issn=0304-3940;citation_author=J S Kim;citation_author=H H Kornhuber;citation_author=W Schmid-Burgk;citation_author=B Holzm체ller"/>
  <meta name="citation_reference" content="citation_title=A polygenic burden of rare disruptive mutations in schizophrenia;citation_publication_date=2014;citation_volume=506;citation_doi=10.1038/nature12975;citation_issn=0028-0836, 1476-4687;citation_author=Shaun M Purcell;citation_author=Jennifer L Moran;citation_author=Menachem Fromer;citation_author=Douglas Ruderfer;citation_author=Nadia Solovieff;citation_author=Panos Roussos;citation_author=Colm O&lt;e2&gt;섵ushlaine;citation_author=Kimberly Chambert;citation_author=Sarah E Bergen;citation_author=Anna K채hler;citation_author=Laramie Duncan;citation_author=Eli Stahl;citation_author=Giulio Genovese;citation_author=Esperanza Fern찼ndez;citation_author=Mark O Collins;citation_author=Noboru H Komiyama;citation_author=Jyoti S Choudhary;citation_author=Patrik K E Magnusson;citation_author=Eric Banks;citation_author=Khalid Shakir;citation_author=Kiran Garimella;citation_author=Tim Fennell;citation_author=Mark DePristo;citation_author=Seth G N Grant;citation_author=Stephen J Haggarty;citation_author=Stacey Gabriel;citation_author=Edward M Scolnick;citation_author=Eric S Lander;citation_author=Christina M Hultman;citation_author=Patrick F Sullivan;citation_author=Steven A McCarroll;citation_author=Pamela Sklar"/>
  <meta name="citation_reference" content="citation_title=Biological insights from 108 schizophrenia-associated genetic loci;citation_publication_date=2014;citation_volume=511;citation_doi=10.1038/nature13595;citation_issn=0028-0836, 1476-4687;citation_author=Biological insights from 108 schizophrenia-associated genetic loci"/>
  <meta name="citation_reference" content="citation_title=Effects of chronic amphetamine treatment on the glutamate concentration in cerebrospinal fluid and brain: Implications for a theory of schizophrenia;citation_publication_date=1981;citation_volume=24;citation_doi=10.1016/0304-3940(81)90365-7;citation_issn=0304-3940;citation_author=J S Kim;citation_author=H H Kornhuber;citation_author=U Brand;citation_author=H G Menge"/>
  <meta name="citation_reference" content="citation_title=Metabotropic glutamate receptors as novel targets for anxiety and stress disorders;citation_publication_date=2005;citation_volume=4;citation_doi=10.1038/nrd1630;citation_issn=1474-1776;citation_author=Chad J Swanson;citation_author=Mark Bures;citation_author=Michael P Johnson;citation_author=Anni-Maija Linden;citation_author=James A Monn;citation_author=Darryle D Schoepp"/>
  <!--radix_placeholder_rmarkdown_metadata-->

  <script type="text/json" id="radix-rmarkdown-metadata">
  {"type":"list","attributes":{"names":{"type":"character","attributes":{},"value":["title","description","bibliography","link-citation"]}},"value":[{"type":"character","attributes":{},"value":["2장 10절: 글루타메이트 가설"]},{"type":"character","attributes":{},"value":["Glutamate Hypothesis"]},{"type":"character","attributes":{},"value":["references/02-10.bib"]},{"type":"logical","attributes":{},"value":[true]}]}
  </script>
  <!--/radix_placeholder_rmarkdown_metadata-->
  <!--radix_placeholder_navigation_in_header-->
  <meta name="distill:offset" content=""/>

  <script type="application/javascript">

    window.headroom_prevent_pin = false;

    window.document.addEventListener("DOMContentLoaded", function (event) {

      // initialize headroom for banner
      var header = $('header').get(0);
      var headerHeight = header.offsetHeight;
      var headroom = new Headroom(header, {
        tolerance: 5,
        onPin : function() {
          if (window.headroom_prevent_pin) {
            window.headroom_prevent_pin = false;
            headroom.unpin();
          }
        }
      });
      headroom.init();
      if(window.location.hash)
        headroom.unpin();
      $(header).addClass('headroom--transition');

      // offset scroll location for banner on hash change
      // (see: https://github.com/WickyNilliams/headroom.js/issues/38)
      window.addEventListener("hashchange", function(event) {
        window.scrollTo(0, window.pageYOffset - (headerHeight + 25));
      });

      // responsive menu
      $('.distill-site-header').each(function(i, val) {
        var topnav = $(this);
        var toggle = topnav.find('.nav-toggle');
        toggle.on('click', function() {
          topnav.toggleClass('responsive');
        });
      });

      // nav dropdowns
      $('.nav-dropbtn').click(function(e) {
        $(this).next('.nav-dropdown-content').toggleClass('nav-dropdown-active');
        $(this).parent().siblings('.nav-dropdown')
           .children('.nav-dropdown-content').removeClass('nav-dropdown-active');
      });
      $("body").click(function(e){
        $('.nav-dropdown-content').removeClass('nav-dropdown-active');
      });
      $(".nav-dropdown").click(function(e){
        e.stopPropagation();
      });
    });
  </script>

  <style type="text/css">

  /* Theme (user-documented overrideables for nav appearance) */

  .distill-site-nav {
    color: rgba(255, 255, 255, 0.8);
    background-color: #0F2E3D;
    font-size: 15px;
    font-weight: 300;
  }

  .distill-site-nav a {
    color: inherit;
    text-decoration: none;
  }

  .distill-site-nav a:hover {
    color: white;
  }

  @media print {
    .distill-site-nav {
      display: none;
    }
  }

  .distill-site-header {

  }

  .distill-site-footer {

  }


  /* Site Header */

  .distill-site-header {
    width: 100%;
    box-sizing: border-box;
    z-index: 3;
  }

  .distill-site-header .nav-left {
    display: inline-block;
    margin-left: 8px;
  }

  @media screen and (max-width: 768px) {
    .distill-site-header .nav-left {
      margin-left: 0;
    }
  }


  .distill-site-header .nav-right {
    float: right;
    margin-right: 8px;
  }

  .distill-site-header a,
  .distill-site-header .title {
    display: inline-block;
    text-align: center;
    padding: 14px 10px 14px 10px;
  }

  .distill-site-header .title {
    font-size: 18px;
    min-width: 150px;
  }

  .distill-site-header .logo {
    padding: 0;
  }

  .distill-site-header .logo img {
    display: none;
    max-height: 20px;
    width: auto;
    margin-bottom: -4px;
  }

  .distill-site-header .nav-image img {
    max-height: 18px;
    width: auto;
    display: inline-block;
    margin-bottom: -3px;
  }



  @media screen and (min-width: 1000px) {
    .distill-site-header .logo img {
      display: inline-block;
    }
    .distill-site-header .nav-left {
      margin-left: 20px;
    }
    .distill-site-header .nav-right {
      margin-right: 20px;
    }
    .distill-site-header .title {
      padding-left: 12px;
    }
  }


  .distill-site-header .nav-toggle {
    display: none;
  }

  .nav-dropdown {
    display: inline-block;
    position: relative;
  }

  .nav-dropdown .nav-dropbtn {
    border: none;
    outline: none;
    color: rgba(255, 255, 255, 0.8);
    padding: 16px 10px;
    background-color: transparent;
    font-family: inherit;
    font-size: inherit;
    font-weight: inherit;
    margin: 0;
    margin-top: 1px;
    z-index: 2;
  }

  .nav-dropdown-content {
    display: none;
    position: absolute;
    background-color: white;
    min-width: 200px;
    border: 1px solid rgba(0,0,0,0.15);
    border-radius: 4px;
    box-shadow: 0px 8px 16px 0px rgba(0,0,0,0.1);
    z-index: 1;
    margin-top: 2px;
    white-space: nowrap;
    padding-top: 4px;
    padding-bottom: 4px;
  }

  .nav-dropdown-content hr {
    margin-top: 4px;
    margin-bottom: 4px;
    border: none;
    border-bottom: 1px solid rgba(0, 0, 0, 0.1);
  }

  .nav-dropdown-active {
    display: block;
  }

  .nav-dropdown-content a, .nav-dropdown-content .nav-dropdown-header {
    color: black;
    padding: 6px 24px;
    text-decoration: none;
    display: block;
    text-align: left;
  }

  .nav-dropdown-content .nav-dropdown-header {
    display: block;
    padding: 5px 24px;
    padding-bottom: 0;
    text-transform: uppercase;
    font-size: 14px;
    color: #999999;
    white-space: nowrap;
  }

  .nav-dropdown:hover .nav-dropbtn {
    color: white;
  }

  .nav-dropdown-content a:hover {
    background-color: #ddd;
    color: black;
  }

  .nav-right .nav-dropdown-content {
    margin-left: -45%;
    right: 0;
  }

  @media screen and (max-width: 768px) {
    .distill-site-header a, .distill-site-header .nav-dropdown  {display: none;}
    .distill-site-header a.nav-toggle {
      float: right;
      display: block;
    }
    .distill-site-header .title {
      margin-left: 0;
    }
    .distill-site-header .nav-right {
      margin-right: 0;
    }
    .distill-site-header {
      overflow: hidden;
    }
    .nav-right .nav-dropdown-content {
      margin-left: 0;
    }
  }


  @media screen and (max-width: 768px) {
    .distill-site-header.responsive {position: relative; min-height: 500px; }
    .distill-site-header.responsive a.nav-toggle {
      position: absolute;
      right: 0;
      top: 0;
    }
    .distill-site-header.responsive a,
    .distill-site-header.responsive .nav-dropdown {
      display: block;
      text-align: left;
    }
    .distill-site-header.responsive .nav-left,
    .distill-site-header.responsive .nav-right {
      width: 100%;
    }
    .distill-site-header.responsive .nav-dropdown {float: none;}
    .distill-site-header.responsive .nav-dropdown-content {position: relative;}
    .distill-site-header.responsive .nav-dropdown .nav-dropbtn {
      display: block;
      width: 100%;
      text-align: left;
    }
  }

  /* Site Footer */

  .distill-site-footer {
    width: 100%;
    overflow: hidden;
    box-sizing: border-box;
    z-index: 3;
    margin-top: 30px;
    padding-top: 30px;
    padding-bottom: 30px;
    text-align: center;
  }

  /* Headroom */

  d-title {
    padding-top: 6rem;
  }

  @media print {
    d-title {
      padding-top: 4rem;
    }
  }

  .headroom {
    z-index: 1000;
    position: fixed;
    top: 0;
    left: 0;
    right: 0;
  }

  .headroom--transition {
    transition: all .4s ease-in-out;
  }

  .headroom--unpinned {
    top: -100px;
  }

  .headroom--pinned {
    top: 0;
  }

  /* adjust viewport for navbar height */
  /* helps vertically center bootstrap (non-distill) content */
  .min-vh-100 {
    min-height: calc(100vh - 100px) !important;
  }

  </style>

  <script src="site_libs/jquery-1.11.3/jquery.min.js"></script>
  <link href="site_libs/font-awesome-5.1.0/css/all.css" rel="stylesheet"/>
  <link href="site_libs/font-awesome-5.1.0/css/v4-shims.css" rel="stylesheet"/>
  <script src="site_libs/headroom-0.9.4/headroom.min.js"></script>
  <script src="site_libs/autocomplete-0.37.1/autocomplete.min.js"></script>
  <script src="site_libs/fuse-6.4.1/fuse.min.js"></script>

  <script type="application/javascript">

  function getMeta(metaName) {
    var metas = document.getElementsByTagName('meta');
    for (let i = 0; i < metas.length; i++) {
      if (metas[i].getAttribute('name') === metaName) {
        return metas[i].getAttribute('content');
      }
    }
    return '';
  }

  function offsetURL(url) {
    var offset = getMeta('distill:offset');
    return offset ? offset + '/' + url : url;
  }

  function createFuseIndex() {

    // create fuse index
    var options = {
      keys: [
        { name: 'title', weight: 20 },
        { name: 'categories', weight: 15 },
        { name: 'description', weight: 10 },
        { name: 'contents', weight: 5 },
      ],
      ignoreLocation: true,
      threshold: 0
    };
    var fuse = new window.Fuse([], options);

    // fetch the main search.json
    return fetch(offsetURL('search.json'))
      .then(function(response) {
        if (response.status == 200) {
          return response.json().then(function(json) {
            // index main articles
            json.articles.forEach(function(article) {
              fuse.add(article);
            });
            // download collections and index their articles
            return Promise.all(json.collections.map(function(collection) {
              return fetch(offsetURL(collection)).then(function(response) {
                if (response.status === 200) {
                  return response.json().then(function(articles) {
                    articles.forEach(function(article) {
                      fuse.add(article);
                    });
                  })
                } else {
                  return Promise.reject(
                    new Error('Unexpected status from search index request: ' +
                              response.status)
                  );
                }
              });
            })).then(function() {
              return fuse;
            });
          });

        } else {
          return Promise.reject(
            new Error('Unexpected status from search index request: ' +
                        response.status)
          );
        }
      });
  }

  window.document.addEventListener("DOMContentLoaded", function (event) {

    // get search element (bail if we don't have one)
    var searchEl = window.document.getElementById('distill-search');
    if (!searchEl)
      return;

    createFuseIndex()
      .then(function(fuse) {

        // make search box visible
        searchEl.classList.remove('hidden');

        // initialize autocomplete
        var options = {
          autoselect: true,
          hint: false,
          minLength: 2,
        };
        window.autocomplete(searchEl, options, [{
          source: function(query, callback) {
            const searchOptions = {
              isCaseSensitive: false,
              shouldSort: true,
              minMatchCharLength: 2,
              limit: 10,
            };
            var results = fuse.search(query, searchOptions);
            callback(results
              .map(function(result) { return result.item; })
            );
          },
          templates: {
            suggestion: function(suggestion) {
              var img = suggestion.preview && Object.keys(suggestion.preview).length > 0
                ? `<img src="${offsetURL(suggestion.preview)}"</img>`
                : '';
              var html = `
                <div class="search-item">
                  <h3>${suggestion.title}</h3>
                  <div class="search-item-description">
                    ${suggestion.description || ''}
                  </div>
                  <div class="search-item-preview">
                    ${img}
                  </div>
                </div>
              `;
              return html;
            }
          }
        }]).on('autocomplete:selected', function(event, suggestion) {
          window.location.href = offsetURL(suggestion.path);
        });
        // remove inline display style on autocompleter (we want to
        // manage responsive display via css)
        $('.algolia-autocomplete').css("display", "");
      })
      .catch(function(error) {
        console.log(error);
      });

  });

  </script>

  <style type="text/css">

  .nav-search {
    font-size: x-small;
  }

  /* Algolioa Autocomplete */

  .algolia-autocomplete {
    display: inline-block;
    margin-left: 10px;
    vertical-align: sub;
    background-color: white;
    color: black;
    padding: 6px;
    padding-top: 8px;
    padding-bottom: 0;
    border-radius: 6px;
    border: 1px #0F2E3D solid;
    width: 180px;
  }


  @media screen and (max-width: 768px) {
    .distill-site-nav .algolia-autocomplete {
      display: none;
      visibility: hidden;
    }
    .distill-site-nav.responsive .algolia-autocomplete {
      display: inline-block;
      visibility: visible;
    }
    .distill-site-nav.responsive .algolia-autocomplete .aa-dropdown-menu {
      margin-left: 0;
      width: 400px;
      max-height: 400px;
    }
  }

  .algolia-autocomplete .aa-input, .algolia-autocomplete .aa-hint {
    width: 90%;
    outline: none;
    border: none;
  }

  .algolia-autocomplete .aa-hint {
    color: #999;
  }
  .algolia-autocomplete .aa-dropdown-menu {
    width: 550px;
    max-height: 70vh;
    overflow-x: visible;
    overflow-y: scroll;
    padding: 5px;
    margin-top: 3px;
    margin-left: -150px;
    background-color: #fff;
    border-radius: 5px;
    border: 1px solid #999;
    border-top: none;
  }

  .algolia-autocomplete .aa-dropdown-menu .aa-suggestion {
    cursor: pointer;
    padding: 5px 4px;
    border-bottom: 1px solid #eee;
  }

  .algolia-autocomplete .aa-dropdown-menu .aa-suggestion:last-of-type {
    border-bottom: none;
    margin-bottom: 2px;
  }

  .algolia-autocomplete .aa-dropdown-menu .aa-suggestion .search-item {
    overflow: hidden;
    font-size: 0.8em;
    line-height: 1.4em;
  }

  .algolia-autocomplete .aa-dropdown-menu .aa-suggestion .search-item h3 {
    font-size: 1rem;
    margin-block-start: 0;
    margin-block-end: 5px;
  }

  .algolia-autocomplete .aa-dropdown-menu .aa-suggestion .search-item-description {
    display: inline-block;
    overflow: hidden;
    height: 2.8em;
    width: 80%;
    margin-right: 4%;
  }

  .algolia-autocomplete .aa-dropdown-menu .aa-suggestion .search-item-preview {
    display: inline-block;
    width: 15%;
  }

  .algolia-autocomplete .aa-dropdown-menu .aa-suggestion .search-item-preview img {
    height: 3em;
    width: auto;
    display: none;
  }

  .algolia-autocomplete .aa-dropdown-menu .aa-suggestion .search-item-preview img[src] {
    display: initial;
  }

  .algolia-autocomplete .aa-dropdown-menu .aa-suggestion.aa-cursor {
    background-color: #eee;
  }
  .algolia-autocomplete .aa-dropdown-menu .aa-suggestion em {
    font-weight: bold;
    font-style: normal;
  }

  </style>


  <!--/radix_placeholder_navigation_in_header-->
  <!--radix_placeholder_distill-->

  <style type="text/css">

  body {
    background-color: white;
  }

  .pandoc-table {
    width: 100%;
  }

  .pandoc-table>caption {
    margin-bottom: 10px;
  }

  .pandoc-table th:not([align]) {
    text-align: left;
  }

  .pagedtable-footer {
    font-size: 15px;
  }

  d-byline .byline {
    grid-template-columns: 2fr 2fr;
  }

  d-byline .byline h3 {
    margin-block-start: 1.5em;
  }

  d-byline .byline .authors-affiliations h3 {
    margin-block-start: 0.5em;
  }

  .authors-affiliations .orcid-id {
    width: 16px;
    height:16px;
    margin-left: 4px;
    margin-right: 4px;
    vertical-align: middle;
    padding-bottom: 2px;
  }

  d-title .dt-tags {
    margin-top: 1em;
    grid-column: text;
  }

  .dt-tags .dt-tag {
    text-decoration: none;
    display: inline-block;
    color: rgba(0,0,0,0.6);
    padding: 0em 0.4em;
    margin-right: 0.5em;
    margin-bottom: 0.4em;
    font-size: 70%;
    border: 1px solid rgba(0,0,0,0.2);
    border-radius: 3px;
    text-transform: uppercase;
    font-weight: 500;
  }

  d-article table.gt_table td,
  d-article table.gt_table th {
    border-bottom: none;
  }

  .html-widget {
    margin-bottom: 2.0em;
  }

  .l-screen-inset {
    padding-right: 16px;
  }

  .l-screen .caption {
    margin-left: 10px;
  }

  .shaded {
    background: rgb(247, 247, 247);
    padding-top: 20px;
    padding-bottom: 20px;
    border-top: 1px solid rgba(0, 0, 0, 0.1);
    border-bottom: 1px solid rgba(0, 0, 0, 0.1);
  }

  .shaded .html-widget {
    margin-bottom: 0;
    border: 1px solid rgba(0, 0, 0, 0.1);
  }

  .shaded .shaded-content {
    background: white;
  }

  .text-output {
    margin-top: 0;
    line-height: 1.5em;
  }

  .hidden {
    display: none !important;
  }

  d-article {
    padding-top: 2.5rem;
    padding-bottom: 30px;
  }

  d-appendix {
    padding-top: 30px;
  }

  d-article>p>img {
    width: 100%;
  }

  d-article h2 {
    margin: 1rem 0 1.5rem 0;
  }

  d-article h3 {
    margin-top: 1.5rem;
  }

  d-article iframe {
    border: 1px solid rgba(0, 0, 0, 0.1);
    margin-bottom: 2.0em;
    width: 100%;
  }

  /* Tweak code blocks */

  d-article div.sourceCode code,
  d-article pre code {
    font-family: Consolas, Monaco, 'Andale Mono', 'Ubuntu Mono', monospace;
  }

  d-article pre,
  d-article div.sourceCode,
  d-article div.sourceCode pre {
    overflow: auto;
  }

  d-article div.sourceCode {
    background-color: white;
  }

  d-article div.sourceCode pre {
    padding-left: 10px;
    font-size: 12px;
    border-left: 2px solid rgba(0,0,0,0.1);
  }

  d-article pre {
    font-size: 12px;
    color: black;
    background: none;
    margin-top: 0;
    text-align: left;
    white-space: pre;
    word-spacing: normal;
    word-break: normal;
    word-wrap: normal;
    line-height: 1.5;

    -moz-tab-size: 4;
    -o-tab-size: 4;
    tab-size: 4;

    -webkit-hyphens: none;
    -moz-hyphens: none;
    -ms-hyphens: none;
    hyphens: none;
  }

  d-article pre a {
    border-bottom: none;
  }

  d-article pre a:hover {
    border-bottom: none;
    text-decoration: underline;
  }

  d-article details {
    grid-column: text;
    margin-bottom: 0.8em;
  }

  @media(min-width: 768px) {

  d-article pre,
  d-article div.sourceCode,
  d-article div.sourceCode pre {
    overflow: visible !important;
  }

  d-article div.sourceCode pre {
    padding-left: 18px;
    font-size: 14px;
  }

  d-article pre {
    font-size: 14px;
  }

  }

  figure img.external {
    background: white;
    border: 1px solid rgba(0, 0, 0, 0.1);
    box-shadow: 0 1px 8px rgba(0, 0, 0, 0.1);
    padding: 18px;
    box-sizing: border-box;
  }

  /* CSS for d-contents */

  .d-contents {
    grid-column: text;
    color: rgba(0,0,0,0.8);
    font-size: 0.9em;
    padding-bottom: 1em;
    margin-bottom: 1em;
    padding-bottom: 0.5em;
    margin-bottom: 1em;
    padding-left: 0.25em;
    justify-self: start;
  }

  @media(min-width: 1000px) {
    .d-contents.d-contents-float {
      height: 0;
      grid-column-start: 1;
      grid-column-end: 4;
      justify-self: center;
      padding-right: 3em;
      padding-left: 2em;
    }
  }

  .d-contents nav h3 {
    font-size: 18px;
    margin-top: 0;
    margin-bottom: 1em;
  }

  .d-contents li {
    list-style-type: none
  }

  .d-contents nav > ul {
    padding-left: 0;
  }

  .d-contents ul {
    padding-left: 1em
  }

  .d-contents nav ul li {
    margin-top: 0.6em;
    margin-bottom: 0.2em;
  }

  .d-contents nav a {
    font-size: 13px;
    border-bottom: none;
    text-decoration: none
    color: rgba(0, 0, 0, 0.8);
  }

  .d-contents nav a:hover {
    text-decoration: underline solid rgba(0, 0, 0, 0.6)
  }

  .d-contents nav > ul > li > a {
    font-weight: 600;
  }

  .d-contents nav > ul > li > ul {
    font-weight: inherit;
  }

  .d-contents nav > ul > li > ul > li {
    margin-top: 0.2em;
  }


  .d-contents nav ul {
    margin-top: 0;
    margin-bottom: 0.25em;
  }

  .d-article-with-toc h2:nth-child(2) {
    margin-top: 0;
  }


  /* Figure */

  .figure {
    position: relative;
    margin-bottom: 2.5em;
    margin-top: 1.5em;
  }

  .figure img {
    width: 100%;
  }

  .figure .caption {
    color: rgba(0, 0, 0, 0.6);
    font-size: 12px;
    line-height: 1.5em;
  }

  .figure img.external {
    background: white;
    border: 1px solid rgba(0, 0, 0, 0.1);
    box-shadow: 0 1px 8px rgba(0, 0, 0, 0.1);
    padding: 18px;
    box-sizing: border-box;
  }

  .figure .caption a {
    color: rgba(0, 0, 0, 0.6);
  }

  .figure .caption b,
  .figure .caption strong, {
    font-weight: 600;
    color: rgba(0, 0, 0, 1.0);
  }

  /* Citations */

  d-article .citation {
    color: inherit;
    cursor: inherit;
  }

  div.hanging-indent{
    margin-left: 1em; text-indent: -1em;
  }

  /* Citation hover box */

  .tippy-box[data-theme~=light-border] {
    background-color: rgba(250, 250, 250, 0.95);
  }

  .tippy-content > p {
    margin-bottom: 0;
    padding: 2px;
  }


  /* Tweak 1000px media break to show more text */

  @media(min-width: 1000px) {
    .base-grid,
    distill-header,
    d-title,
    d-abstract,
    d-article,
    d-appendix,
    distill-appendix,
    d-byline,
    d-footnote-list,
    d-citation-list,
    distill-footer {
      grid-template-columns: [screen-start] 1fr [page-start kicker-start] 80px [middle-start] 50px [text-start kicker-end] 65px 65px 65px 65px 65px 65px 65px 65px [text-end gutter-start] 65px [middle-end] 65px [page-end gutter-end] 1fr [screen-end];
      grid-column-gap: 16px;
    }

    .grid {
      grid-column-gap: 16px;
    }

    d-article {
      font-size: 1.06rem;
      line-height: 1.7em;
    }
    figure .caption, .figure .caption, figure figcaption {
      font-size: 13px;
    }
  }

  @media(min-width: 1180px) {
    .base-grid,
    distill-header,
    d-title,
    d-abstract,
    d-article,
    d-appendix,
    distill-appendix,
    d-byline,
    d-footnote-list,
    d-citation-list,
    distill-footer {
      grid-template-columns: [screen-start] 1fr [page-start kicker-start] 60px [middle-start] 60px [text-start kicker-end] 60px 60px 60px 60px 60px 60px 60px 60px [text-end gutter-start] 60px [middle-end] 60px [page-end gutter-end] 1fr [screen-end];
      grid-column-gap: 32px;
    }

    .grid {
      grid-column-gap: 32px;
    }
  }


  /* Get the citation styles for the appendix (not auto-injected on render since
     we do our own rendering of the citation appendix) */

  d-appendix .citation-appendix,
  .d-appendix .citation-appendix {
    font-size: 11px;
    line-height: 15px;
    border-left: 1px solid rgba(0, 0, 0, 0.1);
    padding-left: 18px;
    border: 1px solid rgba(0,0,0,0.1);
    background: rgba(0, 0, 0, 0.02);
    padding: 10px 18px;
    border-radius: 3px;
    color: rgba(150, 150, 150, 1);
    overflow: hidden;
    margin-top: -12px;
    white-space: pre-wrap;
    word-wrap: break-word;
  }

  /* Include appendix styles here so they can be overridden */

  d-appendix {
    contain: layout style;
    font-size: 0.8em;
    line-height: 1.7em;
    margin-top: 60px;
    margin-bottom: 0;
    border-top: 1px solid rgba(0, 0, 0, 0.1);
    color: rgba(0,0,0,0.5);
    padding-top: 60px;
    padding-bottom: 48px;
  }

  d-appendix h3 {
    grid-column: page-start / text-start;
    font-size: 15px;
    font-weight: 500;
    margin-top: 1em;
    margin-bottom: 0;
    color: rgba(0,0,0,0.65);
  }

  d-appendix h3 + * {
    margin-top: 1em;
  }

  d-appendix ol {
    padding: 0 0 0 15px;
  }

  @media (min-width: 768px) {
    d-appendix ol {
      padding: 0 0 0 30px;
      margin-left: -30px;
    }
  }

  d-appendix li {
    margin-bottom: 1em;
  }

  d-appendix a {
    color: rgba(0, 0, 0, 0.6);
  }

  d-appendix > * {
    grid-column: text;
  }

  d-appendix > d-footnote-list,
  d-appendix > d-citation-list,
  d-appendix > distill-appendix {
    grid-column: screen;
  }

  /* Include footnote styles here so they can be overridden */

  d-footnote-list {
    contain: layout style;
  }

  d-footnote-list > * {
    grid-column: text;
  }

  d-footnote-list a.footnote-backlink {
    color: rgba(0,0,0,0.3);
    padding-left: 0.5em;
  }



  /* Anchor.js */

  .anchorjs-link {
    /*transition: all .25s linear; */
    text-decoration: none;
    border-bottom: none;
  }
  *:hover > .anchorjs-link {
    margin-left: -1.125em !important;
    text-decoration: none;
    border-bottom: none;
  }

  /* Social footer */

  .social_footer {
    margin-top: 30px;
    margin-bottom: 0;
    color: rgba(0,0,0,0.67);
  }

  .disqus-comments {
    margin-right: 30px;
  }

  .disqus-comment-count {
    border-bottom: 1px solid rgba(0, 0, 0, 0.4);
    cursor: pointer;
  }

  #disqus_thread {
    margin-top: 30px;
  }

  .article-sharing a {
    border-bottom: none;
    margin-right: 8px;
  }

  .article-sharing a:hover {
    border-bottom: none;
  }

  .sidebar-section.subscribe {
    font-size: 12px;
    line-height: 1.6em;
  }

  .subscribe p {
    margin-bottom: 0.5em;
  }


  .article-footer .subscribe {
    font-size: 15px;
    margin-top: 45px;
  }


  .sidebar-section.custom {
    font-size: 12px;
    line-height: 1.6em;
  }

  .custom p {
    margin-bottom: 0.5em;
  }

  /* Styles for listing layout (hide title) */
  .layout-listing d-title, .layout-listing .d-title {
    display: none;
  }

  /* Styles for posts lists (not auto-injected) */


  .posts-with-sidebar {
    padding-left: 45px;
    padding-right: 45px;
  }

  .posts-list .description h2,
  .posts-list .description p {
    font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, Oxygen, Ubuntu, Cantarell, "Fira Sans", "Droid Sans", "Helvetica Neue", Arial, sans-serif;
  }

  .posts-list .description h2 {
    font-weight: 700;
    border-bottom: none;
    padding-bottom: 0;
  }

  .posts-list h2.post-tag {
    border-bottom: 1px solid rgba(0, 0, 0, 0.2);
    padding-bottom: 12px;
  }
  .posts-list {
    margin-top: 60px;
    margin-bottom: 24px;
  }

  .posts-list .post-preview {
    text-decoration: none;
    overflow: hidden;
    display: block;
    border-bottom: 1px solid rgba(0, 0, 0, 0.1);
    padding: 24px 0;
  }

  .post-preview-last {
    border-bottom: none !important;
  }

  .posts-list .posts-list-caption {
    grid-column: screen;
    font-weight: 400;
  }

  .posts-list .post-preview h2 {
    margin: 0 0 6px 0;
    line-height: 1.2em;
    font-style: normal;
    font-size: 24px;
  }

  .posts-list .post-preview p {
    margin: 0 0 12px 0;
    line-height: 1.4em;
    font-size: 16px;
  }

  .posts-list .post-preview .thumbnail {
    box-sizing: border-box;
    margin-bottom: 24px;
    position: relative;
    max-width: 500px;
  }
  .posts-list .post-preview img {
    width: 100%;
    display: block;
  }

  .posts-list .metadata {
    font-size: 12px;
    line-height: 1.4em;
    margin-bottom: 18px;
  }

  .posts-list .metadata > * {
    display: inline-block;
  }

  .posts-list .metadata .publishedDate {
    margin-right: 2em;
  }

  .posts-list .metadata .dt-authors {
    display: block;
    margin-top: 0.3em;
    margin-right: 2em;
  }

  .posts-list .dt-tags {
    display: block;
    line-height: 1em;
  }

  .posts-list .dt-tags .dt-tag {
    display: inline-block;
    color: rgba(0,0,0,0.6);
    padding: 0.3em 0.4em;
    margin-right: 0.2em;
    margin-bottom: 0.4em;
    font-size: 60%;
    border: 1px solid rgba(0,0,0,0.2);
    border-radius: 3px;
    text-transform: uppercase;
    font-weight: 500;
  }

  .posts-list img {
    opacity: 1;
  }

  .posts-list img[data-src] {
    opacity: 0;
  }

  .posts-more {
    clear: both;
  }


  .posts-sidebar {
    font-size: 16px;
  }

  .posts-sidebar h3 {
    font-size: 16px;
    margin-top: 0;
    margin-bottom: 0.5em;
    font-weight: 400;
    text-transform: uppercase;
  }

  .sidebar-section {
    margin-bottom: 30px;
  }

  .categories ul {
    list-style-type: none;
    margin: 0;
    padding: 0;
  }

  .categories li {
    color: rgba(0, 0, 0, 0.8);
    margin-bottom: 0;
  }

  .categories li>a {
    border-bottom: none;
  }

  .categories li>a:hover {
    border-bottom: 1px solid rgba(0, 0, 0, 0.4);
  }

  .categories .active {
    font-weight: 600;
  }

  .categories .category-count {
    color: rgba(0, 0, 0, 0.4);
  }


  @media(min-width: 768px) {
    .posts-list .post-preview h2 {
      font-size: 26px;
    }
    .posts-list .post-preview .thumbnail {
      float: right;
      width: 30%;
      margin-bottom: 0;
    }
    .posts-list .post-preview .description {
      float: left;
      width: 45%;
    }
    .posts-list .post-preview .metadata {
      float: left;
      width: 20%;
      margin-top: 8px;
    }
    .posts-list .post-preview p {
      margin: 0 0 12px 0;
      line-height: 1.5em;
      font-size: 16px;
    }
    .posts-with-sidebar .posts-list {
      float: left;
      width: 75%;
    }
    .posts-with-sidebar .posts-sidebar {
      float: right;
      width: 20%;
      margin-top: 60px;
      padding-top: 24px;
      padding-bottom: 24px;
    }
  }


  /* Improve display for browsers without grid (IE/Edge <= 15) */

  .downlevel {
    line-height: 1.6em;
    font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, Oxygen, Ubuntu, Cantarell, "Fira Sans", "Droid Sans", "Helvetica Neue", Arial, sans-serif;
    margin: 0;
  }

  .downlevel .d-title {
    padding-top: 6rem;
    padding-bottom: 1.5rem;
  }

  .downlevel .d-title h1 {
    font-size: 50px;
    font-weight: 700;
    line-height: 1.1em;
    margin: 0 0 0.5rem;
  }

  .downlevel .d-title p {
    font-weight: 300;
    font-size: 1.2rem;
    line-height: 1.55em;
    margin-top: 0;
  }

  .downlevel .d-byline {
    padding-top: 0.8em;
    padding-bottom: 0.8em;
    font-size: 0.8rem;
    line-height: 1.8em;
  }

  .downlevel .section-separator {
    border: none;
    border-top: 1px solid rgba(0, 0, 0, 0.1);
  }

  .downlevel .d-article {
    font-size: 1.06rem;
    line-height: 1.7em;
    padding-top: 1rem;
    padding-bottom: 2rem;
  }


  .downlevel .d-appendix {
    padding-left: 0;
    padding-right: 0;
    max-width: none;
    font-size: 0.8em;
    line-height: 1.7em;
    margin-bottom: 0;
    color: rgba(0,0,0,0.5);
    padding-top: 40px;
    padding-bottom: 48px;
  }

  .downlevel .footnotes ol {
    padding-left: 13px;
  }

  .downlevel .base-grid,
  .downlevel .distill-header,
  .downlevel .d-title,
  .downlevel .d-abstract,
  .downlevel .d-article,
  .downlevel .d-appendix,
  .downlevel .distill-appendix,
  .downlevel .d-byline,
  .downlevel .d-footnote-list,
  .downlevel .d-citation-list,
  .downlevel .distill-footer,
  .downlevel .appendix-bottom,
  .downlevel .posts-container {
    padding-left: 40px;
    padding-right: 40px;
  }

  @media(min-width: 768px) {
    .downlevel .base-grid,
    .downlevel .distill-header,
    .downlevel .d-title,
    .downlevel .d-abstract,
    .downlevel .d-article,
    .downlevel .d-appendix,
    .downlevel .distill-appendix,
    .downlevel .d-byline,
    .downlevel .d-footnote-list,
    .downlevel .d-citation-list,
    .downlevel .distill-footer,
    .downlevel .appendix-bottom,
    .downlevel .posts-container {
    padding-left: 150px;
    padding-right: 150px;
    max-width: 900px;
  }
  }

  .downlevel pre code {
    display: block;
    border-left: 2px solid rgba(0, 0, 0, .1);
    padding: 0 0 0 20px;
    font-size: 14px;
  }

  .downlevel code, .downlevel pre {
    color: black;
    background: none;
    font-family: Consolas, Monaco, 'Andale Mono', 'Ubuntu Mono', monospace;
    text-align: left;
    white-space: pre;
    word-spacing: normal;
    word-break: normal;
    word-wrap: normal;
    line-height: 1.5;

    -moz-tab-size: 4;
    -o-tab-size: 4;
    tab-size: 4;

    -webkit-hyphens: none;
    -moz-hyphens: none;
    -ms-hyphens: none;
    hyphens: none;
  }

  .downlevel .posts-list .post-preview {
    color: inherit;
  }



  </style>

  <script type="application/javascript">

  function is_downlevel_browser() {
    if (bowser.isUnsupportedBrowser({ msie: "12", msedge: "16"},
                                   window.navigator.userAgent)) {
      return true;
    } else {
      return window.load_distill_framework === undefined;
    }
  }

  // show body when load is complete
  function on_load_complete() {

    // add anchors
    if (window.anchors) {
      window.anchors.options.placement = 'left';
      window.anchors.add('d-article > h2, d-article > h3, d-article > h4, d-article > h5');
    }


    // set body to visible
    document.body.style.visibility = 'visible';

    // force redraw for leaflet widgets
    if (window.HTMLWidgets) {
      var maps = window.HTMLWidgets.findAll(".leaflet");
      $.each(maps, function(i, el) {
        var map = this.getMap();
        map.invalidateSize();
        map.eachLayer(function(layer) {
          if (layer instanceof L.TileLayer)
            layer.redraw();
        });
      });
    }

    // trigger 'shown' so htmlwidgets resize
    $('d-article').trigger('shown');
  }

  function init_distill() {

    init_common();

    // create front matter
    var front_matter = $('<d-front-matter></d-front-matter>');
    $('#distill-front-matter').wrap(front_matter);

    // create d-title
    $('.d-title').changeElementType('d-title');

    // create d-byline
    var byline = $('<d-byline></d-byline>');
    $('.d-byline').replaceWith(byline);

    // create d-article
    var article = $('<d-article></d-article>');
    $('.d-article').wrap(article).children().unwrap();

    // move posts container into article
    $('.posts-container').appendTo($('d-article'));

    // create d-appendix
    $('.d-appendix').changeElementType('d-appendix');

    // flag indicating that we have appendix items
    var appendix = $('.appendix-bottom').children('h3').length > 0;

    // replace footnotes with <d-footnote>
    $('.footnote-ref').each(function(i, val) {
      appendix = true;
      var href = $(this).attr('href');
      var id = href.replace('#', '');
      var fn = $('#' + id);
      var fn_p = $('#' + id + '>p');
      fn_p.find('.footnote-back').remove();
      var text = fn_p.html();
      var dtfn = $('<d-footnote></d-footnote>');
      dtfn.html(text);
      $(this).replaceWith(dtfn);
    });
    // remove footnotes
    $('.footnotes').remove();

    // move refs into #references-listing
    $('#references-listing').replaceWith($('#refs'));

    $('h1.appendix, h2.appendix').each(function(i, val) {
      $(this).changeElementType('h3');
    });
    $('h3.appendix').each(function(i, val) {
      var id = $(this).attr('id');
      $('.d-contents a[href="#' + id + '"]').parent().remove();
      appendix = true;
      $(this).nextUntil($('h1, h2, h3')).addBack().appendTo($('d-appendix'));
    });

    // show d-appendix if we have appendix content
    $("d-appendix").css('display', appendix ? 'grid' : 'none');

    // localize layout chunks to just output
    $('.layout-chunk').each(function(i, val) {

      // capture layout
      var layout = $(this).attr('data-layout');

      // apply layout to markdown level block elements
      var elements = $(this).children().not('details, div.sourceCode, pre, script');
      elements.each(function(i, el) {
        var layout_div = $('<div class="' + layout + '"></div>');
        if (layout_div.hasClass('shaded')) {
          var shaded_content = $('<div class="shaded-content"></div>');
          $(this).wrap(shaded_content);
          $(this).parent().wrap(layout_div);
        } else {
          $(this).wrap(layout_div);
        }
      });


      // unwrap the layout-chunk div
      $(this).children().unwrap();
    });

    // remove code block used to force  highlighting css
    $('.distill-force-highlighting-css').parent().remove();

    // remove empty line numbers inserted by pandoc when using a
    // custom syntax highlighting theme
    $('code.sourceCode a:empty').remove();

    // load distill framework
    load_distill_framework();

    // wait for window.distillRunlevel == 4 to do post processing
    function distill_post_process() {

      if (!window.distillRunlevel || window.distillRunlevel < 4)
        return;

      // hide author/affiliations entirely if we have no authors
      var front_matter = JSON.parse($("#distill-front-matter").html());
      var have_authors = front_matter.authors && front_matter.authors.length > 0;
      if (!have_authors)
        $('d-byline').addClass('hidden');

      // article with toc class
      $('.d-contents').parent().addClass('d-article-with-toc');

      // strip links that point to #
      $('.authors-affiliations').find('a[href="#"]').removeAttr('href');

      // add orcid ids
      $('.authors-affiliations').find('.author').each(function(i, el) {
        var orcid_id = front_matter.authors[i].orcidID;
        if (orcid_id) {
          var a = $('<a></a>');
          a.attr('href', 'https://orcid.org/' + orcid_id);
          var img = $('<img></img>');
          img.addClass('orcid-id');
          img.attr('alt', 'ORCID ID');
          img.attr('src','data:image/png;base64,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');
          a.append(img);
          $(this).append(a);
        }
      });

      // hide elements of author/affiliations grid that have no value
      function hide_byline_column(caption) {
        $('d-byline').find('h3:contains("' + caption + '")').parent().css('visibility', 'hidden');
      }

      // affiliations
      var have_affiliations = false;
      for (var i = 0; i<front_matter.authors.length; ++i) {
        var author = front_matter.authors[i];
        if (author.affiliation !== "&nbsp;") {
          have_affiliations = true;
          break;
        }
      }
      if (!have_affiliations)
        $('d-byline').find('h3:contains("Affiliations")').css('visibility', 'hidden');

      // published date
      if (!front_matter.publishedDate)
        hide_byline_column("Published");

      // document object identifier
      var doi = $('d-byline').find('h3:contains("DOI")');
      var doi_p = doi.next().empty();
      if (!front_matter.doi) {
        // if we have a citation and valid citationText then link to that
        if ($('#citation').length > 0 && front_matter.citationText) {
          doi.html('Citation');
          $('<a href="#citation"></a>')
            .text(front_matter.citationText)
            .appendTo(doi_p);
        } else {
          hide_byline_column("DOI");
        }
      } else {
        $('<a></a>')
           .attr('href', "https://doi.org/" + front_matter.doi)
           .html(front_matter.doi)
           .appendTo(doi_p);
      }

       // change plural form of authors/affiliations
      if (front_matter.authors.length === 1) {
        var grid = $('.authors-affiliations');
        grid.children('h3:contains("Authors")').text('Author');
        grid.children('h3:contains("Affiliations")').text('Affiliation');
      }

      // remove d-appendix and d-footnote-list local styles
      $('d-appendix > style:first-child').remove();
      $('d-footnote-list > style:first-child').remove();

      // move appendix-bottom entries to the bottom
      $('.appendix-bottom').appendTo('d-appendix').children().unwrap();
      $('.appendix-bottom').remove();

      // hoverable references
      $('span.citation[data-cites]').each(function() {
        var refs = $(this).attr('data-cites').split(" ");
        var refHtml = refs.map(function(ref) {
          return "<p>" + $('#ref-' + ref).html() + "</p>";
        }).join("\n");
        window.tippy(this, {
          allowHTML: true,
          content: refHtml,
          maxWidth: 500,
          interactive: true,
          interactiveBorder: 10,
          theme: 'light-border',
          placement: 'bottom-start'
        });
      });

      // clear polling timer
      clearInterval(tid);

      // show body now that everything is ready
      on_load_complete();
    }

    var tid = setInterval(distill_post_process, 50);
    distill_post_process();

  }

  function init_downlevel() {

    init_common();

     // insert hr after d-title
    $('.d-title').after($('<hr class="section-separator"/>'));

    // check if we have authors
    var front_matter = JSON.parse($("#distill-front-matter").html());
    var have_authors = front_matter.authors && front_matter.authors.length > 0;

    // manage byline/border
    if (!have_authors)
      $('.d-byline').remove();
    $('.d-byline').after($('<hr class="section-separator"/>'));
    $('.d-byline a').remove();

    // remove toc
    $('.d-contents').remove();

    // move appendix elements
    $('h1.appendix, h2.appendix').each(function(i, val) {
      $(this).changeElementType('h3');
    });
    $('h3.appendix').each(function(i, val) {
      $(this).nextUntil($('h1, h2, h3')).addBack().appendTo($('.d-appendix'));
    });


    // inject headers into references and footnotes
    var refs_header = $('<h3></h3>');
    refs_header.text('References');
    $('#refs').prepend(refs_header);

    var footnotes_header = $('<h3></h3');
    footnotes_header.text('Footnotes');
    $('.footnotes').children('hr').first().replaceWith(footnotes_header);

    // move appendix-bottom entries to the bottom
    $('.appendix-bottom').appendTo('.d-appendix').children().unwrap();
    $('.appendix-bottom').remove();

    // remove appendix if it's empty
    if ($('.d-appendix').children().length === 0)
      $('.d-appendix').remove();

    // prepend separator above appendix
    $('.d-appendix').before($('<hr class="section-separator" style="clear: both"/>'));

    // trim code
    $('pre>code').each(function(i, val) {
      $(this).html($.trim($(this).html()));
    });

    // move posts-container right before article
    $('.posts-container').insertBefore($('.d-article'));

    $('body').addClass('downlevel');

    on_load_complete();
  }


  function init_common() {

    // jquery plugin to change element types
    (function($) {
      $.fn.changeElementType = function(newType) {
        var attrs = {};

        $.each(this[0].attributes, function(idx, attr) {
          attrs[attr.nodeName] = attr.nodeValue;
        });

        this.replaceWith(function() {
          return $("<" + newType + "/>", attrs).append($(this).contents());
        });
      };
    })(jQuery);

    // prevent underline for linked images
    $('a > img').parent().css({'border-bottom' : 'none'});

    // mark non-body figures created by knitr chunks as 100% width
    $('.layout-chunk').each(function(i, val) {
      var figures = $(this).find('img, .html-widget');
      if ($(this).attr('data-layout') !== "l-body") {
        figures.css('width', '100%');
      } else {
        figures.css('max-width', '100%');
        figures.filter("[width]").each(function(i, val) {
          var fig = $(this);
          fig.css('width', fig.attr('width') + 'px');
        });

      }
    });

    // auto-append index.html to post-preview links in file: protocol
    // and in rstudio ide preview
    $('.post-preview').each(function(i, val) {
      if (window.location.protocol === "file:")
        $(this).attr('href', $(this).attr('href') + "index.html");
    });

    // get rid of index.html references in header
    if (window.location.protocol !== "file:") {
      $('.distill-site-header a[href]').each(function(i,val) {
        $(this).attr('href', $(this).attr('href').replace("index.html", "./"));
      });
    }

    // add class to pandoc style tables
    $('tr.header').parent('thead').parent('table').addClass('pandoc-table');
    $('.kable-table').children('table').addClass('pandoc-table');

    // add figcaption style to table captions
    $('caption').parent('table').addClass("figcaption");

    // initialize posts list
    if (window.init_posts_list)
      window.init_posts_list();

    // implmement disqus comment link
    $('.disqus-comment-count').click(function() {
      window.headroom_prevent_pin = true;
      $('#disqus_thread').toggleClass('hidden');
      if (!$('#disqus_thread').hasClass('hidden')) {
        var offset = $(this).offset();
        $(window).resize();
        $('html, body').animate({
          scrollTop: offset.top - 35
        });
      }
    });
  }

  document.addEventListener('DOMContentLoaded', function() {
    if (is_downlevel_browser())
      init_downlevel();
    else
      window.addEventListener('WebComponentsReady', init_distill);
  });

  </script>

  <style type="text/css">
  /* base variables */

  /* Edit the CSS properties in this file to create a custom
     Distill theme. Only edit values in the right column
     for each row; values shown are the CSS defaults.
     To return any property to the default,
     you may set its value to: unset
     All rows must end with a semi-colon.                      */

  /* Optional: embed custom fonts here with `@import`          */
  /* This must remain at the top of this file.                 */



  html {
    /*-- Main font sizes --*/
    --title-size:      50px;
    --body-size:       1.06rem;
    --code-size:       14px;
    --aside-size:      12px;
    --fig-cap-size:    13px;
    /*-- Main font colors --*/
    --title-color:     #000000;
    --header-color:    rgba(0, 0, 0, 0.8);
    --body-color:      rgba(0, 0, 0, 0.8);
    --aside-color:     rgba(0, 0, 0, 0.6);
    --fig-cap-color:   rgba(0, 0, 0, 0.6);
    /*-- Specify custom fonts ~~~ must be imported above   --*/
    --heading-font:    sans-serif;
    --mono-font:       monospace;
    --body-font:       sans-serif;
    --navbar-font:     sans-serif;  /* websites + blogs only */
  }

  /*-- ARTICLE METADATA --*/
  d-byline {
    --heading-size:    0.6rem;
    --heading-color:   rgba(0, 0, 0, 0.5);
    --body-size:       0.8rem;
    --body-color:      rgba(0, 0, 0, 0.8);
  }

  /*-- ARTICLE TABLE OF CONTENTS --*/
  .d-contents {
    --heading-size:    18px;
    --contents-size:   13px;
  }

  /*-- ARTICLE APPENDIX --*/
  d-appendix {
    --heading-size:    15px;
    --heading-color:   rgba(0, 0, 0, 0.65);
    --text-size:       0.8em;
    --text-color:      rgba(0, 0, 0, 0.5);
  }

  /*-- WEBSITE HEADER + FOOTER --*/
  /* These properties only apply to Distill sites and blogs  */

  .distill-site-header {
    --title-size:       18px;
    --text-color:       rgba(255, 255, 255, 0.8);
    --text-size:        15px;
    --hover-color:      white;
    --bkgd-color:       #0F2E3D;
  }

  .distill-site-footer {
    --text-color:       rgba(255, 255, 255, 0.8);
    --text-size:        15px;
    --hover-color:      white;
    --bkgd-color:       #0F2E3D;
  }

  /*-- Additional custom styles --*/
  /* Add any additional CSS rules below                      */
  </style>
  <style type="text/css">
  /* base variables */

  /* Edit the CSS properties in this file to create a custom
     Distill theme. Only edit values in the right column
     for each row; values shown are the CSS defaults.
     To return any property to the default,
     you may set its value to: unset
     All rows must end with a semi-colon.                      */

  /* Optional: embed custom fonts here with `@import`          */
  /* This must remain at the top of this file.                 */

  @import url('https://fonts.googleapis.com/css?family=Noto+Serif+KR');
  @import url('https://fonts.googleapis.com/css2?family=Noto+Sans+KR:wght@300&display=swap');

  html {
    /*-- Main font sizes --*/
    --title-size:      50px;
    --body-size:       1.06rem;
    --code-size:       14px;
    --aside-size:      12px;
    --fig-cap-size:    13px;
    /*-- Main font colors --*/
    --title-color:     #000000;
    --header-color:    rgba(0, 0, 0, 0.8);
    --body-color:      rgba(0, 0, 0, 0.8);
    --aside-color:     rgba(0, 0, 0, 0.6);
    --fig-cap-color:   rgba(0, 0, 0, 0.6);
    /*-- Specify custom fonts ~~~ must be imported above   --*/
    --heading-font:    'Noto Sans Kr', sans-serif;
    --mono-font:       monospace;
    --body-font:       'Noto Serif KR', sans-serif;
    --navbar-font:     'Noto Sans Kr', sans-serif;  /* websites + blogs only */
  }

  /*-- ASIDE --*/

  d-article aside {
    width: 150%;
  }

  d-article aside li {
    line-height: 0.8rem
  }

  /*-- a concept explained in ASIDE --*/

  s {
    color: cadetblue;
    text-emphasis-style: dot;
    text-decoration-line: none;
    
  }

  /*-- ARTICLE METADATA --*/
  d-byline {
    --heading-size:    0.6rem;
    --heading-color:   rgba(0, 0, 0, 0.5);
    --body-size:       0.8rem;
    --body-color:      rgba(0, 0, 0, 0.8);
  }

  /*-- ARTICLE TABLE OF CONTENTS --*/

  .d-contents {
    --heading-size:    1.4rem;
    --contents-size:   0.8rem;
  }

  @media (min-width: 1000px) {
    .d-contents.d-contents-float {
        position: fixed;
        top: 20%;
        left: 2%;
        width: 16%;
    }
  }


  /*-- ARTICLE APPENDIX --*/
  d-appendix {
    --heading-size:    15px;
    --heading-color:   rgba(0, 0, 0, 0.65);
    --text-size:       0.8em;
    --text-color:      rgba(0, 0, 0, 0.5);
  }

  /*-- WEBSITE HEADER + FOOTER --*/
  /* These properties only apply to Distill sites and blogs  */

  .distill-site-header {
    --title-size:       18px;
    --text-color:       rgba(255, 255, 255, 0.8);
    --text-size:        15px;
    --hover-color:      white;
    --bkgd-color:       #0F2E3D;
  }

  .distill-site-footer {
    --text-color:       rgba(255, 255, 255, 0.8);
    --text-size:        15px;
    --hover-color:      white;
    --bkgd-color:       #0F2E3D;
  }

  /*-- Additional custom styles --*/
  /* Add any additional CSS rules below                      */

  d-article {
    contain: none !important;
  }

  d-contents .figcaption {
    line-height: 2rem;
  }

  figure {
    margin: 1rem auto;
    width: 75%;
  }


  figure figcaption,
  .figcaption p {
    border-bottom: 1px dotted black;
  }

  i.arrow {
    position: fixed;
    font-size: 5rem;
    top: 50%;
    color: rgb(25, 0, 125);
    opacity: 0.1;
  }

  i.arrow:hover {
    opacity: 0.5;
  }

  i.fa-arrow-alt-circle-left {
    left: 5%;
  }

  i.fa-arrow-alt-circle-right {
    right: 5%;
  }

  .title_box {
    position: relative; 
    background-color: white;
    width: 700px; 
  }

  .title_box li {
    list-style-type: none;
  }

  .title_border:before {
      content: "";
      background: linear-gradient(130deg,#ff7a18,#af002d 41.07%,#319197 76.05%);
      position: absolute;
      top: -5px;
      left: -5px;
      width: calc(100% + 10px);
      height: calc(100% + 10px);
      z-index: -1;
      border-radius: 12px;
  }

  .title_inside {
    padding: 20px;
  }

  d-article a {
    border-bottom: none;
    opacity: 0.6;
  }
  d-article a:hover {
    opacity: 1;
    color: color: rgb(25, 0, 125);
    border-bottom: none;
  }

  .d-contents nav a {
    text-decoration: none;
    border-bottom: none;
    opacity: 0.6;
  }
  .d-contents nav a:hover {
    text-decoration: none;
    border-bottom: none;
    opacity: 1;
  }

  /* Table decoration  */
  table td {
    vertical-align: top;
  }</style>
  <style type="text/css">
  /* base style */

  /* FONT FAMILIES */

  :root {
    --heading-default: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, Oxygen, Ubuntu, Cantarell, "Fira Sans", "Droid Sans", "Helvetica Neue", Arial, sans-serif;
    --mono-default: Consolas, Monaco, 'Andale Mono', 'Ubuntu Mono', monospace;
    --body-default: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, Oxygen, Ubuntu, Cantarell, "Fira Sans", "Droid Sans", "Helvetica Neue", Arial, sans-serif;
  }

  body,
  .posts-list .post-preview p,
  .posts-list .description p {
    font-family: var(--body-font), var(--body-default);
  }

  h1, h2, h3, h4, h5, h6,
  .posts-list .post-preview h2,
  .posts-list .description h2 {
    font-family: var(--heading-font), var(--heading-default);
  }

  d-article div.sourceCode code,
  d-article pre code {
    font-family: var(--mono-font), var(--mono-default);
  }


  /*-- TITLE --*/
  d-title h1,
  .posts-list > h1 {
    color: var(--title-color, black);
  }

  d-title h1 {
    font-size: var(--title-size, 50px);
  }

  /*-- HEADERS --*/
  d-article h1,
  d-article h2,
  d-article h3,
  d-article h4,
  d-article h5,
  d-article h6 {
    color: var(--header-color, rgba(0, 0, 0, 0.8));
  }

  /*-- BODY --*/
  d-article > p,  /* only text inside of <p> tags */
  d-article > ul, /* lists */
  d-article > ol {
    color: var(--body-color, rgba(0, 0, 0, 0.8));
    font-size: var(--body-size, 1.06rem);
  }


  /*-- CODE --*/
  d-article div.sourceCode code,
  d-article pre code {
    font-size: var(--code-size, 14px);
  }

  /*-- ASIDE --*/
  d-article aside {
    font-size: var(--aside-size, 12px);
    color: var(--aside-color, rgba(0, 0, 0, 0.6));
  }

  /*-- FIGURE CAPTIONS --*/
  figure .caption,
  figure figcaption,
  .figure .caption {
    font-size: var(--fig-cap-size, 13px);
    color: var(--fig-cap-color, rgba(0, 0, 0, 0.6));
  }

  /*-- METADATA --*/
  d-byline h3 {
    font-size: var(--heading-size, 0.6rem);
    color: var(--heading-color, rgba(0, 0, 0, 0.5));
  }

  d-byline {
    font-size: var(--body-size, 0.8rem);
    color: var(--body-color, rgba(0, 0, 0, 0.8));
  }

  d-byline a,
  d-article d-byline a {
    color: var(--body-color, rgba(0, 0, 0, 0.8));
  }

  /*-- TABLE OF CONTENTS --*/
  .d-contents nav h3 {
    font-size: var(--heading-size, 18px);
  }

  .d-contents nav a {
    font-size: var(--contents-size, 13px);
  }

  /*-- APPENDIX --*/
  d-appendix h3 {
    font-size: var(--heading-size, 15px);
    color: var(--heading-color, rgba(0, 0, 0, 0.65));
  }

  d-appendix {
    font-size: var(--text-size, 0.8em);
    color: var(--text-color, rgba(0, 0, 0, 0.5));
  }

  d-appendix d-footnote-list a.footnote-backlink {
    color: var(--text-color, rgba(0, 0, 0, 0.5));
  }

  /*-- WEBSITE HEADER + FOOTER --*/
  .distill-site-header .title {
    font-size: var(--title-size, 18px);
    font-family: var(--navbar-font), var(--heading-default);
  }

  .distill-site-header a,
  .nav-dropdown .nav-dropbtn {
    font-family: var(--navbar-font), var(--heading-default);
  }

  .nav-dropdown .nav-dropbtn {
    color: var(--text-color, rgba(255, 255, 255, 0.8));
    font-size: var(--text-size, 15px);
  }

  .distill-site-header a:hover,
  .nav-dropdown:hover .nav-dropbtn {
    color: var(--hover-color, white);
  }

  .distill-site-header {
    font-size: var(--text-size, 15px);
    color: var(--text-color, rgba(255, 255, 255, 0.8));
    background-color: var(--bkgd-color, #0F2E3D);
  }

  .distill-site-footer {
    font-size: var(--text-size, 15px);
    color: var(--text-color, rgba(255, 255, 255, 0.8));
    background-color: var(--bkgd-color, #0F2E3D);
  }

  .distill-site-footer a:hover {
    color: var(--hover-color, white);
  }</style>
  <!--/radix_placeholder_distill-->
  <script src="site_libs/header-attrs-2.7/header-attrs.js"></script>
  <script src="site_libs/popper-2.6.0/popper.min.js"></script>
  <link href="site_libs/tippy-6.2.7/tippy.css" rel="stylesheet" />
  <link href="site_libs/tippy-6.2.7/tippy-light-border.css" rel="stylesheet" />
  <script src="site_libs/tippy-6.2.7/tippy.umd.min.js"></script>
  <script src="site_libs/anchor-4.2.2/anchor.min.js"></script>
  <script src="site_libs/bowser-1.9.3/bowser.min.js"></script>
  <script src="site_libs/webcomponents-2.0.0/webcomponents.js"></script>
  <script src="site_libs/distill-2.2.21/template.v2.js"></script>
  <!--radix_placeholder_site_in_header-->
  <!--/radix_placeholder_site_in_header-->


</head>

<body>

<!--radix_placeholder_front_matter-->

<script id="distill-front-matter" type="text/json">
{"title":"2장 10절: 글루타메이트 가설","description":"Glutamate Hypothesis","authors":[]}
</script>

<!--/radix_placeholder_front_matter-->
<!--radix_placeholder_navigation_before_body-->
<header class="header header--fixed" role="banner">
<nav class="distill-site-nav distill-site-header">
<div class="nav-left">
<a class="logo">
<img src="images/logo2.png" alt="Logo"/>
</a>
<a href="index.html" class="title">KYS study group</a>
<input id="distill-search" class="nav-search hidden" type="text" placeholder="Search..."/>
</div>
<div class="nav-right">
<a href="index.html">Front Matter</a>
<div class="nav-dropdown">
<button class="nav-dropbtn">
Contents
 
<span class="down-arrow">&#x25BE;</span>
</button>
<div class="nav-dropdown-content">
<a href="frontmatter-01.html">1. Understanding of Schizophrenia</a>
<a href="frontmatter-02.html">2. Biological Basis of Schizophrenia</a>
<a href="frontmatter-03.html">3. History of Antipsychotic Treatment</a>
<a href="frontmatter-04.html">4. Basic Concetps in Antipsychotic Treatment</a>
</div>
</div>
<a href="about.html">Authors</a>
<a href="https://github.com/AnselmJeong/distill">
<i class="fab fa-github" aria-hidden="true"></i>
</a>
<a href="javascript:void(0);" class="nav-toggle">&#9776;</a>
</div>
</nav>
</header>
<!--/radix_placeholder_navigation_before_body-->
<!--radix_placeholder_site_before_body-->
<!--/radix_placeholder_site_before_body-->

<div class="d-title">
<h1>2장 10절: 글루타메이트 가설</h1>
<!--radix_placeholder_categories-->
<!--/radix_placeholder_categories-->
<p>Glutamate Hypothesis</p>
</div>


<div class="d-article">
<div class="d-contents d-contents-float">
<nav class="l-text toc figcaption" id="TOC">
<h3>Contents</h3>
<ul>
<li><a href="#글루타메이트-신호전달">10-1. 글루타메이트 신호전달</a></li>
<li><a href="#글루타메이트-가설의-등장">10-2. 글루타메이트 가설의 등장</a></li>
<li><a href="#유전적-증거">10-3. 유전적 증거</a></li>
<li><a href="#NMDA">10-4. NMDA 수용체 기능 부전의 생리적 효과</a></li>
<li><a href="#excitotoxicity">10-5. 흥분성 독성</a></li>
<li><a href="#치료적-함의">10-6. 치료적 함의</a></li>
</ul>
</nav>
</div>
<p><a href="article-02-09.html"><i class="arrow far fa-arrow-alt-circle-left"></i></a></p>
<p><a href="article-02-11.html"><i class="arrow far fa-arrow-alt-circle-right"></i></a></p>
<h2 id="글루타메이트-신호전달">10-1. 글루타메이트 신호전달</h2>
<p>글루타메이트는 중추신경계의 대표적인 흥분성 신경전달물질로서, 뇌에서 일어나는 신호전달의 90% 이상을 담당하고 있다. 이러한 중요성에도 불구하고, 신경전달물질로서의 정체가 명확히 규명된 것은 도파민, 세로토닌보다도 늦은 1984년에 이르러서였다.<span class="citation" data-cites="Fonnum1984-cm">(<a href="#ref-Fonnum1984-cm" role="doc-biblioref">Fonnum 1984</a>)</span> 글루타메이트는 그 자체가 신경전달물질일 뿐 아니라, 대표적인 억제성 신경전달물질인 GABA의 전구물질이기도 하며, 둘은 서로 상보적으로 작용하여 신호전달의 균형을 이룬다.</p>
<p>글루타메이트 수용체는 AMPA/kinate과 NMDA 수용체라 불리우는 이온채널을 비롯하여, G 단백질과 결합되어 있는 metabotropic 수용체로 나뉜다. 통상적인 정보전달 이외에도, NMDA 수용체를 통한 신호전달을 중심으로 하여 학습/기억에 핵심적인 역할을 하기 때문에 다양한 정신질환과 관련해서 연구되었다.</p>
<figure>
<img src="images/02-10/img_0.png" id="fig:glutamate-neurotransmission" alt="Figure 1. Glutamate neurotransmission from (Swanson et al. 2005)" /><figcaption aria-hidden="true">Figure 1. Glutamate neurotransmission<br />
from <span class="citation" data-cites="Swanson2005-ah">(<a href="#ref-Swanson2005-ah" role="doc-biblioref">Swanson et al. 2005</a>)</span></figcaption>
</figure>
<h2 id="글루타메이트-가설의-등장">10-2. 글루타메이트 가설의 등장</h2>
<p>도파민 가설이 조현병의 양성 증상을 설명하기 위해 등장하였다면, 글루타메이트 가설은 음성/인지 증상을 설명하기 위해 등장했다고 해도 과언이 아니다. 신경발달학적 가설과 신경퇴행적 가설이 점점 더 영향력을 얻어가면서, 연구자들의 관심은 신경연결망의 형성과 유지 그리고 붕괴에 쏠리기 시작하였다. 조현병 환자는 발병 초반부터 뇌실질의 위축이 관찰되고, 만성화, 황폐화 정도에 따라 이러한 위축이 점점 더 심해지는 소견을 보인다. 따라서 연결망이 애초에 만들어질 때부터 문제가 있을 뿐더러, 출생 후에도 이를 유지하고 상황에 맞게 변형시키는데 어려움을 겪을 것이라 예상되었다.</p>
<p>이와 더불어 1970년대 마취 보조제로 도입된 <s>ketamine</s>과 <s>phencyclidine (PCP)</s>은 특징적으로 조현병 유사 증상을 유발했는데, 암페타민 유발 정신증과는 달리, 음성/인지 증상에 해당되는 증상도 일으킬 수 있었다.<span class="citation" data-cites="Krystal1994-vn">(<a href="#ref-Krystal1994-vn" role="doc-biblioref">Krystal et al. 1994</a>)</span> 때문에 암페타민이나 LSD 복용 후 정신 증상을 일으켜 병원을 찾은 환자들에 대해선 의사들이 쉽게 감별진단을 할 수 있었던 것에 비해, PCP/ketamine 복용 후 방문한 환자들에게는 대부분 조현병 진단이 내려졌다.<span class="citation" data-cites="Uno2019-mx">(<a href="#ref-Uno2019-mx" role="doc-biblioref">Uno and Coyle 2019</a>)</span> 또한 실제 조현병 환자가 PCP를 복용하면, 기존의 증상이 훨씬 악화되는 현상을 보였다.<span class="citation" data-cites="Lahti1995-co">(<a href="#ref-Lahti1995-co" role="doc-biblioref">Lahti et al. 1995</a>)</span></p>
<aside>
<p><strong>Ketamine</strong>: 1962년에 합성된 마취제. 원래 동물 마취 및 치과용 마취에 사용되었다. 강력한 진통작용과 함께 환각을 일으킨다. 환자는 표면적으로는 의식이 있는 것처럼 보이지만, 나중에 과정을 기억하지 못하기 때문에 해리성 마취제로도 불리운다. 미다졸람, 프로포폴과 함께 가장 많이 사용되는 수면마취제이지만, 남용 위험이 높으며 과량 투여 시 심혈관계 불안정으로 사망할 수 있다.</p>
<p><strong>Phencyclidine</strong>: 소위 angel dust로 불리우는 환각제이다. 1926년에 합성되어 마취제로 사용되었지만 남용 위험이 워낙 높아 ketamine으로 대체되었다. PCP 중독 환자가 나중에 조현병으로 발병하는 비율은 26% 정도로 대마초보다는 낮지만, 필로폰, 코카인 보다는 상당히 높다.<span class="citation" data-cites="Murrie2020-jo">(<a href="#ref-Murrie2020-jo" role="doc-biblioref">Murrie et al. 2020</a>)</span></p>
</aside>
<p>Ketamine과 PCP가 결합하는 부위가 NMDA 수용체라는 글루타메이트 수용체의 하나라는 것은 1980년대 초가 되서야 밝혀졌다. 두 약물은 NMDA의 비경쟁적 길항제이기 때문에, NMDA 신호전달을 원천적으로 차단해버린다. NMDA 수용체는 세가지 서로 다른 종류의 아단위(subunit)가 복합체를 이룬 형태로 구성되며, 그 내부에는 글리신, D-serine, glutathione, spermine 등 다양한 조절물질이 결합하는 부위가 있다 (<a href="#fig:NMDA-receptor">그림 2</a>).<span class="citation" data-cites="Uno2019-mx">(<a href="#ref-Uno2019-mx" role="doc-biblioref">Uno and Coyle 2019</a>)</span></p>
<figure>
<img src="images/02-10/img_1.png" id="fig:NMDA-receptor" width="789" alt="Figure 2. Model of NMDA receptor from (Witt, Macdonald, and Kirkpatrick 2004)" /><figcaption aria-hidden="true">Figure 2. Model of NMDA receptor<br />
from <span class="citation" data-cites="Witt2004-of">(<a href="#ref-Witt2004-of" role="doc-biblioref">Witt, Macdonald, and Kirkpatrick 2004</a>)</span></figcaption>
</figure>
<p>글루타메이트 가설이 최초로 등장한 것은 1980년이다. 근거는 조현병 환자의 뇌척수액에서 글루타메이트 농도가 떨어진다는 것과, 쥐에 암페타민을 투여하면 역시 뇌척수액의 글루타메이트가 감소한다는 것이었다. 이에 연구자들은 글루타메이트 신경세포의 기능 부전 혹은 퇴행이 조현병의 원인이라고 생각하였다.<span class="citation" data-cites="Kim1980-yq">(<a href="#ref-Kim1980-yq" role="doc-biblioref">Kim et al. 1980</a>)</span><span class="citation" data-cites="Kim1981-mf">(<a href="#ref-Kim1981-mf" role="doc-biblioref">Kim et al. 1981</a>)</span> 당시에는 이러한 결과가 타 연구진에 의해 재현되지 않않기 때문에 그다지 관심을 받지 못하였다. 그러던 중 몇년 후 Javitt은 조현병의 PCP 모델이 암페타민 모델보다 더욱 조현병을 설명하는데 유용하다고 주장하면서, 글루타메이트 가설을 본격적으로 회자시킨다.<span class="citation" data-cites="Javitt1987-xw">(<a href="#ref-Javitt1987-xw" role="doc-biblioref">Javitt 1987</a>)</span><span class="citation" data-cites="Javitt1991-fu">(<a href="#ref-Javitt1991-fu" role="doc-biblioref">Javitt and Zukin 1991</a>)</span> 한문장으로 요약하여, 글루타메이트 신호전달 특히 NMDA 수용체를 통한 신호전달이 제대로 이루어지지 않으면 조현병의 제반 증상이 출현한다는 것이다. NMDA 수용체가 기능을 하지 못하면 시냅스의 생성, 유지에 곤란을 겪을 것이다. 게다가 NMDA 수용체를 통한 신호전달은 전전두엽이 피질하 도파민 활성을 조절하는 주요 기전이므로(6-6절 참조), 피질 하 도파민 활성의 부적절한 증가가 초래될 수 있다.</p>
<p>항 NMDA 수용체 자가항체에 의한 뇌염(Anti-NMDA receptor encephalitis) 역시 글루타메이트 가설을 뒷받침하는 증거이다.(<a href="article-02-05.html#autoimmunity">2장 5-5절 참조</a>) 이는 자가면역 질환의 하나로, 급격한 정신병적 증상을 일으키며, 또 순수한 조현병 환자 중에도 일부 항 NMDA 수용체 자가항체가 발견된다. 이러한 증거들은 적어도 조현병 환자 중 일부는 NMDA 수용체 기능 저하때문에 증상이 지속되고 있음을 시사해준다.</p>
<h2 id="유전적-증거">10-3. 유전적 증거</h2>
<p>조현병의 신경발달학적 가설에서는 유전적 요인 혹은 주산기 감염과 같은 환경적 요인이 정상적인 신경발달 과정을 방해한다고 가정한다. 그런데 뉴런과 뉴런 사이에 시냅스가 형성되고, 그것이 점점 강화되어 자리를 잡기 위해선 NMDA를 통한 신경가소성 과정이 절대적으로 중요하다. 따라서 신경발달을 방해하는 유전적 요인이 글루타메이트와 관련되어 있을 것이라 예상하는 것은 상당한 개연성이 있다. 2014년 Schizophrenia Psychiatric GWAS Consortium에서 발표한 광범위 유전체 연합 연구(GWAS, <a href="artible-02-01.html#GWAS">2장 1-5절 참조</a>) 결과를 살펴보면, 엄격한 기준으로 선택된 100여개 정도의 조현병 취약성 유전자에 GRM3, GRIN2A, SRR, GRIA1, CLCN3, SLC38A7, RIMS1, CACNB2, CACNA1C 등 글루타메이트 수용체 발현 유전자가 포함되어 있다.<span class="citation" data-cites="Schizophrenia_Working_Group_of_the_Psychiatric_Genomics_Consortium2014-ve">(<a href="#ref-Schizophrenia_Working_Group_of_the_Psychiatric_Genomics_Consortium2014-ve" role="doc-biblioref">Schizophrenia Working Group of the Psychiatric Genomics Consortium 2014</a>)</span></p>
<p>Ketamine을 투여하면 NMDA 수용체가 차단되고, 이에 대한 반작용으로 뇌 일부분에서 글루타메이트 농도가 증가한다. 이에 비해 조현병 환자들은 유의한 정도로 변연계, 기저핵, 시상 등에서 글루타메이트의 농도가 항시 증가되어 있다.<span class="citation" data-cites="Merritt2016-bk">(<a href="#ref-Merritt2016-bk" role="doc-biblioref">Merritt et al. 2016</a>)</span> 이러한 글루타메이트 활성의 증가는 해마 용적의 감소와 더불어 집행 기능 결함과도 상관관계에 놓여있다.<span class="citation" data-cites="Poels2014-wu">(<a href="#ref-Poels2014-wu" role="doc-biblioref">Poels et al. 2014</a>)</span> Bustillo 등<span class="citation" data-cites="Bustillo2017-cj">(<a href="#ref-Bustillo2017-cj" role="doc-biblioref">Bustillo et al. 2017</a>)</span><strong>​</strong>은 GWAS 결과에서 선정된 글루타메이트 관련 취약성 유전자들을 이용하여 다유전자 위험 점수(Polygenic Risk Scoring, <a href="article-02-01.html#influence-genetic-research">2장 1-6절 참조</a>)를 계산한 후 이를 뇌 내 글루타메이트 활성과 비교하였다. 그 결과 둘 사이의 유의한 양의 상관관계를 찾아내었다.</p>
<p>이와 더불어 부모로부터 물려받은 변이는 아니지만, 생식 세포 복제 과정에서 생기는 변이인 드 노보 변이(de novo mutation, <a href="article-02-01.html#stress-brain">2장 2-1절 참조</a>)가 NMDA 수용체에 생겼을 때 조현병이 발생할 위험이 크게 높아진다고 한다. 이는 주로 유전자 복제수 변이(CNV, <a href="article-02-03.html#neurodevelopment-evidence">2장 3-2절 참조</a>)를 이용하여 조사되었는데, 시냅스의 밀도와 기능에 관계하는 유전자들의 복제수와 발병 위험간의 연관성이 발견되었다.<span class="citation" data-cites="Purcell2014-do">(<a href="#ref-Purcell2014-do" role="doc-biblioref">Purcell et al. 2014</a>)</span><span class="citation" data-cites="Fromer2014-ie">(<a href="#ref-Fromer2014-ie" role="doc-biblioref">Fromer et al. 2014</a>)</span></p>
<h2 id="NMDA">10-4. NMDA 수용체 기능 부전의 생리적 효과</h2>
<p>그러나 NMDA 수용체 기능 부전이 정확히 어떤 식으로 조현병을 일으키는 지는 알려져 있지 않다. 뇌 전역을 아우르는 신경 진동(neural oscillation)은 글루타메이트 활성과 GABA 활성의 섬세한 균형에 의해 유지된다. parvalbumin을 발현하며, GABA를 분비하는 사이뉴런에는 NMDA 수용체가 높은 농도로 분포한다. 이들 수용체가 기능을 하지 못하면 사이뉴런의 활성이 떨어져 글루타메이트/GABA의 균형이 깨지며, 감마 밴드 진동에 문제가 생긴다 (<a href="article-02-06.html#gamma-band">2장 6-5절 참조</a>).<span class="citation" data-cites="Jadi2016-zz">(<a href="#ref-Jadi2016-zz" role="doc-biblioref">Jadi, Behrens, and Sejnowski 2016</a>)</span> 감마 밴드 진동은 뇌의 각 영역이 주어진 과업을 수행하기 위해 동조되는데 중요한 역할을 하기 때문에, 이 진동이 깨지면 조현병 환자의 특징적인 인지과업 수행 저하가 발생할 수 있다.</p>
<p>NMDA 수용체의 문제는 도파민 활성을 높일 수도 낮출 수도 있다. 전술한 바와 같이 GABA 분비 사이뉴런의 활성이 떨어지면, 도파민의 탈억제가 일어나 피질하 도파민 활성이 증가할 수 있다. 역으로 조현병 환자들은 NMDA 기능 부전에 대한 보상작용으로 글루타메이트 농도가 증가되어 있기 때문에, GABA 분비 사이뉴런을 지나치게 자극하여 중피질계 경로에서의 도파민 분비를 저하시킬 수도 있다.<span class="citation" data-cites="Ellaithy2015-dj">(<a href="#ref-Ellaithy2015-dj" role="doc-biblioref">Ellaithy et al. 2015</a>)</span> 더군다나 NMDA를 통한 신호전달은 세로토닌에 의해서도 조절을 받고 있기 때문에, 더더욱 어느 한 방향으로 고정되어 움직인다고 말하기 어렵다.<span class="citation" data-cites="Yuen2008-sj">(<a href="#ref-Yuen2008-sj" role="doc-biblioref">Yuen et al. 2008</a>)</span></p>
<p>최근에는 신경발달과정에서 NMDA 수용체가 담당하는 중요성을 강조하는 <s>methylazoxymethanol acetate (MAM) 모델</s>이 등장하였다.<span class="citation" data-cites="Lodge2009-em">(<a href="#ref-Lodge2009-em" role="doc-biblioref">Lodge and Grace 2009</a>)</span> 임신한 지 17일 된 쥐에게 MAM을 주사하면, 태어난 생쥐가 성인이 되었을 때 조현병과 유사한 다양한 신경생학적, 생리학적, 해부학적, 행동적 이상을 보인다는 모델이다. MAM을 투여받은 산모에게서 태어난 쥐는 NMDA 수용체 아단위에 구조적 이상이 발견되며, 이는 도파민 과활성이나 인지장애가 나타나기 이전부터 시작된다.<span class="citation" data-cites="Gulchina2017-wh">(<a href="#ref-Gulchina2017-wh" role="doc-biblioref">Gulchina et al. 2017</a>)</span> 이 결과는 NMDA 수용체 이상과 이에 따른 시냅스 구조 결함이 추후에 부상하는 도파민 활성 이상의 원인이 될 수 있음을 시사한다. 더욱 흥미로운 것은 MAM 모델 쥐에게 대사성 글루타메이트 수용체 효현제인 LY379268를 청소년 시기에게 투여하면 NMDA 수용체 기능저하와 인지기능 저하를 예방할 수 있었던 반면, 성인기에 투여하면 아무런 효과가 없었다는 점이다.<span class="citation" data-cites="Xing2018-si">(<a href="#ref-Xing2018-si" role="doc-biblioref">Xing et al. 2018</a>)</span></p>
<aside>
<p><strong>Methylazoxymethanol acetate (MAM)</strong>: 식물에서 발견되는 신경독소로 신경아세포에 주로 작용하며, DNA를 알킬화하여 복제를 방해한다. 착상 후 17일째 되는 쥐의 배아에 MAM을 투여한 후 태어난 쥐는, 조현병과 흡사한 행동적, 해부학적 변화를 보이기 때문에 조현병의 동물모델로 사용된다.</p>
</aside>
<h2 id="excitotoxicity">10-5. 흥분성 독성</h2>
<p>앞절까지는 글루타메이트 신호전달이 원할하지 않아 생기는 문제만을 살펴보았다. 그러나 보상 작용에 의해 뇌의 일부 영역에 글루타메이트 농도가 증가되어 있다는 것은 그 자체로 또 다른 문제를 일으킬 수 있으며, 그 대표적인 예가 흥분성 독성(excitotoxicity)이다. 흥분성 독성이란 신경전달물질의 종류를 막론하고 과다한 신호전달이 전해질 때 일어나지만, 가장 대표적인 예는 NMDA 수용체를 통한 흥분성 독성(excitotoxicity)이다. 1950년대 중반부터 동물에게 과량의 글루타메이트를 투여하면 경련발작을 일으키며, 특정 신경세포층이 파괴된다는 것이 알려져 왔다. 1969년 Olney는 이 현상에 대해 “흥분성 독성”이라는 이름을 붙였으며, 이 현상은 글루타메이트 수용체가 있는 시냅스 후 뉴런에 국한된다는 것도 확인하였다. <span class="citation" data-cites="Olney1969-vi">(<a href="#ref-Olney1969-vi" role="doc-biblioref">Olney 1969</a>)</span></p>
<figure>
<img src="images/02-10/img_2.png" id="fig:MRS" alt="Proton magnetic resonance spectroscopy of the left hippocampus in patients with schizophrenia. Cr: creatine, Cho: choline, Glx: glutamate, NAA: N-acetyl aspartate from (Briend et al. 2020)" /><figcaption aria-hidden="true">Proton magnetic resonance spectroscopy of the left hippocampus in patients with schizophrenia.<br />
Cr: creatine, Cho: choline, Glx: glutamate, NAA: N-acetyl aspartate<br />
from <span class="citation" data-cites="Briend2020-gb">(<a href="#ref-Briend2020-gb" role="doc-biblioref">Briend et al. 2020</a>)</span></figcaption>
</figure>
<p>뇌 내에 글루타메이트가 증가되어 있다는 것은 <sup>1</sup>H‐MRS (proton magnetic resonance spectroscopy)를 이용하여 입증할 수 있다. 뇌 내의 일부 저분자량 화합물들은 독특한 MR shift spectrum을 갖고 있기 때문에 <sup>1</sup>H‐MRS를 이용하면 생체 내에서 각 화합물의 농도를 측정할 수 있다. 그러나 MR shift spectrum이 근접한 물질들은 서로 구분하기 어려운데, 그렇기 때문에 글루타메이트, 글루타민(glutamine), GABA, 글루타치온(glutathione)은 함께 측정되며 이를 합쳐 Glx (Glutamine-Glutamate-GABA complex)라고 부른다 (<a href="#fig:MRS">그림 3</a>). Merritt 등<span class="citation" data-cites="Merritt2016-bk">(<a href="#ref-Merritt2016-bk" role="doc-biblioref">Merritt et al. 2016</a>)</span><strong>​</strong>이 행한 메타 연구에서 조현병 환자는 대조군에 비해 기저핵, 시상, 내측 측두엽 등에서 유의하게 Glx가 높아져 있었다. 적어도 대조군에 비해 Glx가 감소되어 있는 뇌 영역은 한 군데도 찾을 수 없었다. 보상성으로 글루타메이트 농도가 높아지는 과정에도 GABA 분비 사이뉴런이 관여한다. NMDA 수용체가 막혀 사이뉴런의 활성이 떨어지면, 시냅스 후 피라미드 뉴런의 탈억제가 일어나고, 여기서 글루타메이트 분비가 증가한다. 이 피라미드 뉴런은 동시에 복측 피개의 도파민 분비 세포에도 연접하여 도파민 분비를 증가시킨다.</p>
<p>NMDA 수용체 전달이 차단되어 신경가소성이 방해를 받으면서 시냅스 연결이 줄어들고 시냅스 농도가 낮아져서 조현병에서 보이는 신경연결망의 잠식이 일어난다. 그러나 글루타메이트 자체의 독성때문에도 희소돌기 아교세포와 신경세포가 사멸하는 등 구조적 변화가 생길 수 있다. 신경세포가 어떻게든 사멸만은 면한다 해도, 전자가 죽어나가기 시작하면 미엘린 수초가 현저하게 줄어들고 백질의 연결성(white matter integrity)이 붕괴되기 시작한다 (<a href="article-02-04.html#neurodegenerative-evidence">2장 4-2절 참조</a>).</p>
<p>글루나메이트의 농도가 지나치게 높아지면 신경세포의 기능장애나 사멸이 일어날 수 있다. NMDA 수용체를 포함하여 AMPA 수용체등 글루타메이트 친화성 이온 채널은 모두 Ca<sup>2+</sup> 채널이다. 지나친 탈분극으로 Ca<sup>2+</sup>이 세포내에 유입되면 세포막에 위치한 Ca<sup>2+</sup> 들이 무리하게 작동을 해야만 하며 이때 엄청나게 많은 양의 ATP를 소모한다.</p>
<p>Excitotoxicity의 정확한 기전은 아직도 연구중이나, 크게 세가지 기전을 통한다.<span class="citation" data-cites="Dong2009-qx">(<a href="#ref-Dong2009-qx" role="doc-biblioref">Dong, Wang, and Qin 2009</a>)</span> 우선 지나친 탈분극에 의해 급격히 유입되는 Na<sup>+</sup>, Cl <sup>-</sup>, Ca<sup>2+</sup> 등 이온들을, 세포밖으로 배출하는 펌프의 역량이 따라가지 못하게 되면, 삼투압이 높아지면서 세포막이 터지게 된다.<span class="citation" data-cites="Beck2003-pn">(<a href="#ref-Beck2003-pn" role="doc-biblioref">Beck et al. 2003</a>)</span> 둘째 Ca<sup>2+</sup> 농도가 상승하면 calcineurin, calpain, caspase 등의 효소가 활성화되는데, 이들은 세포자멸사(<a href="article-02-04.html#neurodegenerative-evidence">2장 4-2절 참조</a>)를 유도하는 대표적인 효소들이다.<span class="citation" data-cites="Pina-Crespo2014-by">(<a href="#ref-Pina-Crespo2014-by" role="doc-biblioref">Piña-Crespo, Sanz-Blasco, and Lipton 2014</a>)</span> 셋째, 세포질 내에 축적된 Ca<sup>2+</sup>은 미토콘드리아로 내부로도 침투하게 되는데, 가뜩이나 이온 펌프 작동을 ATP를 과도하게 생성하고 있는 중이라 <s>반응성 산소종</s> 등 다양한 산화물질이 걷잡을 수 없이 생성된다. 세포 내 항산화 효소가 이들을 중화하는데 실패하면, 단백질, 핵산 등의 구조가 변성되면서 미토콘드리아는 ATP 생성을 더 이상 하지 못하게 된다. 에너지를 생성해내지 못하는 세포는 Ca<sup>2+</sup>을 세포 밖으로 뽑아내지 못하며, 세포 내 상황은 더욱 악화된다.<span class="citation" data-cites="Stavrovskaya2005-lh">(<a href="#ref-Stavrovskaya2005-lh" role="doc-biblioref">Stavrovskaya and Kristal 2005</a>)</span></p>
<aside>
<p><strong>반응성 산소종 (reactive oxygen species)</strong>: 세포 내에서 생성되는 산소 원자의 화합물로 생체 조직을 공격하고 세포를 손상시키는 산화력이 강한 산소이다. 짝지어지지 않고 자유롭게 존재하는 전자 때문에 반응성이 매우 높다. 세포 대사과정에서 저절로 생기기도 하고, 자외선이나 열 등 스트레스에 의해 생기기도 한다. 세포 내에는 산소의 침투를 방어하는 항산화 기전 역시 갖추고 있다.</p>
</aside>
<p>세포 밖 상황도 마찬가지로 어려워진다. 신호전달을 마친 글루타메이트는 글루타메이트 수송체(glutamate transporter)를 통하여 근방의 교세포 등으로 재흡수된다. 그러나 ATP 생성 부진으로 수송체가 제 역할을 발휘하지 못하면, 재흡수 되지 못하고 시냅스 간극에 머무르게 된 글루타메이트가 반복해서 NMDA 수용체를 자극한다.<span class="citation" data-cites="Li2001-ck">(<a href="#ref-Li2001-ck" role="doc-biblioref">Li and Stys 2001</a>)</span></p>
<p>이렇듯 글루타메이트 신호전달이 일정한 역치를 넘어서면 악순환에 빠지면서 신경 세포가 제대로 기능을 못하고 자멸사가 유도된다. 이상의 기전은 조현병 뿐 아니라, 허혈성 뇌졸중, 헌팅턴 병, 파킨슨 병 및 알츠하이머 치매에서도 뱔견되는 현상으로, 조현병의 신경퇴행가설을 설명할 때 중점적으로 논의되고 있다.</p>
<h2 id="치료적-함의">10-6. 치료적 함의</h2>
<p>글루타메이트 가설은 조현병 환자의 신경퇴행 현상을 설명할 뿐 아니라, D<sub>2</sub> 수용체 차단제를 넘어서서 새로운 약물을 개발하는데 견인차 역할을 하였다. NMDA 수용체라는 명칭의 기원이된 NMDA(N-methyl-D-aspartate)를 효현제로서 투여해볼 수도 있겠으나, 이는 흥분성 독성을 일으킬 위험이 높다. 따라서 초창기에 시도되었던 약물은 NMDA 수용체에 결합하여 “다른 자리 입체성 조절(allosteric modulation)”을 행하는 D-serine과 글리신(glycine)이었다.</p>
<p>두 물질은 모두 NMDA 수용체 내부의 특정 부위에 결합하여 글루타메이트 간의 결합력을 증가시킨다. D-serine과 유사한 D-cycloserine은 원래 결핵약으로 개발되었는데, NMDA의 부분효현제로서 작용한다. 1990년대 중반부터 이들 물질은 항정신병 약물과 병용투여하여 음성증상을 개선해보고자 하는 임상 시험이 진행되었다.<span class="citation" data-cites="Javitt1994-to">(<a href="#ref-Javitt1994-to" role="doc-biblioref">Javitt et al. 1994</a>)</span><span class="citation" data-cites="Heresco-Levy1996-tw">(<a href="#ref-Heresco-Levy1996-tw" role="doc-biblioref">Heresco-Levy et al. 1996</a>)</span> 당시만 해도 상당히 고무적인 결과가 얻어졌고, 틀에 박힌 항정신병 약물 개발의 틀에서 벗어날 수 있다는 흥분으로 말미암아, 많은 연구자들이 이 분야에 파고들었다. 1990년대 중반부터 약 10여년간 집중적으로 연구가 이어졌으나, 이 시기에 얻어진 결과는 그다지 희망적이지 못하였다.<span class="citation" data-cites="Singh2011-um">(<a href="#ref-Singh2011-um" role="doc-biblioref">Singh and Singh 2011</a>)</span> 대체로 음성, 인지 증상에 도움이 된다는 연구가 많았으나, 효과 크기는 크지 않았으며, 역설적으로 클로자핀과 병용 투여하면 오히려 양성 증상이 악화된다는 보고도 있었다.<span class="citation" data-cites="Potkin1999-mt">(<a href="#ref-Potkin1999-mt" role="doc-biblioref">Potkin et al. 1999</a>)</span> 이러한 논란을 잠재우고자, Buchanan 등<span class="citation" data-cites="Buchanan2007-jy">(<a href="#ref-Buchanan2007-jy" role="doc-biblioref">Buchanan et al. 2007</a>)</span><strong>​</strong>은 다기관이 참여하는 대형 연구인 “The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST)”을 진행하였다. 이중맹검 무작위 배정으로 16주간 glicine, D-cycloserine 그리고 위약을 비교했던 이 연구에서 배정약물은 음성/인지 증상 개선에 아무런 효과를 보이지 못하였다. 이로써 지난 10여년간의 흥분과 기대는 금새 사그러들게 되었다.</p>
<p>그러나 글루타메이트 가설을 기초로 한 신약 개발은 근근히 이어졌다. 위에 언급한 약물 이외에도 글루타메이트 활성을 조절하는 다양한 경로를 차단/자극하는 약물이 개발되었다. Sarcosine은 글리신의 재흡수를 담당하는 글리신 수송체(glycine transporter, GlyT‐1) 차단제이며, 글리신의 농도를 높여준다.<span class="citation" data-cites="Uno2019-mx">(<a href="#ref-Uno2019-mx" role="doc-biblioref">Uno and Coyle 2019</a>)</span> 또 다른 GlyT‐1 차단제인 bitopertin은 3상 임상시험까지 진행되었으나 효과 부족으로 중도에 탈락하였다. N-acetyl-cysteine (NAC)은 아미노산인 L-cysteine의 전구물질이며, L-cysteine의 산회되면 L-cystine이 된다. 후자는 글리신의 역수송체(glycine antiporter)의 활성을 조절하며, 몇 단계를 거쳐 뉴런의 글루타메이트 분비를 감소시킨다.<span class="citation" data-cites="McQueen2018-ad">(<a href="#ref-McQueen2018-ad" role="doc-biblioref">McQueen et al. 2018</a>)</span> Sodium benzoate은 D-serine을 분해하는 DAAO 효소의 억제제이다.<span class="citation" data-cites="Uno2019-mx">(<a href="#ref-Uno2019-mx" role="doc-biblioref">Uno and Coyle 2019</a>)</span></p>
<p>AMPA, NMDA 수용체 뿐 아니라 대사성 글루타메이트 수용체 관련여부도 활발히 연구되었다. 대사성 수용체 효현제인 pomaglumetad methionil (POM)은 아직 별다른 성과를 보이지 못하고 있으나 활발히 연구가 진행중이다.<span class="citation" data-cites="Sonnenschein2020-vd">(<a href="#ref-Sonnenschein2020-vd" role="doc-biblioref">Sonnenschein and Grace 2020</a>)</span> Phosphodiesterase (PDE)는 글루타메이트가 수용체에 결합하고 난 이후의 신호전달을 조절하는 효소이다. 따라서 이를 차단하면 지나치게 상승된 글루타메이트의 효과를 무마할 수 있다. PDE는 무려 11개의 아형이 있으며, 그 각각이 조현병을 비롯한 다양한 정신질환에서 차지하는 역할을 규명하려는 연구가 활발히 진행되고 있다.<span class="citation" data-cites="Heckman2018-tz">(<a href="#ref-Heckman2018-tz" role="doc-biblioref">Heckman et al. 2018</a>)</span> 새롭게 개발되는 조현병 치료제로서는 Rolipram, BI 409306, roflumilast 등이 임상 시험 중에 있다.<span class="citation" data-cites="Snyder2017-rd">(<a href="#ref-Snyder2017-rd" role="doc-biblioref">Snyder and Vanover 2017</a>)</span><span class="citation" data-cites="Brown2019-be">(<a href="#ref-Brown2019-be" role="doc-biblioref">Brown et al. 2019</a>)</span><span class="citation" data-cites="Gilleen2021-xt">(<a href="#ref-Gilleen2021-xt" role="doc-biblioref">Gilleen et al. 2021</a>)</span></p>
<div class="sourceCode" id="cb1"><pre class="sourceCode r distill-force-highlighting-css"><code class="sourceCode r"></code></pre></div>
<div id="refs" class="references csl-bib-body hanging-indent" role="doc-bibliography">
<div id="ref-Beck2003-pn" class="csl-entry" role="doc-biblioentry">
Beck, Joe, Brett Lenart, Douglas B Kintner, and Dandan Sun. 2003. <span>“<span>Na-K-Cl</span> Cotransporter Contributes to Glutamate-Mediated Excitotoxicity.”</span> <em>J. Neurosci.</em> 23 (12): 5061–68.
</div>
<div id="ref-Briend2020-gb" class="csl-entry" role="doc-biblioentry">
Briend, Frédéric, Eric A Nelson, Omar Maximo, William P Armstrong, Nina V Kraguljac, and Adrienne C Lahti. 2020. <span>“Hippocampal Glutamate and Hippocampus Subfield Volumes in Antipsychotic-Naive First Episode Psychosis Subjects and Relationships to Duration of Untreated Psychosis.”</span> <em>Transl. Psychiatry</em> 10 (1): 137. <a href="https://doi.org/10.1038/s41398-020-0812-z">https://doi.org/10.1038/s41398-020-0812-z</a>.
</div>
<div id="ref-Brown2019-be" class="csl-entry" role="doc-biblioentry">
Brown, David, Kazuyuki Nakagome, Joachim Cordes, Ronald Brenner, Gerhard Gründer, Richard S E Keefe, Robert Riesenberg, et al. 2019. <span>“Evaluation of the Efficacy, Safety, and Tolerability of <span>BI</span> 409306, a Novel Phosphodiesterase 9 Inhibitor, in Cognitive Impairment in Schizophrenia: A Randomized, <span>Double-Blind</span>, <span>Placebo-Controlled</span>, Phase <span>II</span> Trial.”</span> <em>Schizophr. Bull.</em> 45 (2): 350–59. <a href="https://doi.org/10.1093/schbul/sby049">https://doi.org/10.1093/schbul/sby049</a>.
</div>
<div id="ref-Buchanan2007-jy" class="csl-entry" role="doc-biblioentry">
Buchanan, Robert W, Daniel C Javitt, Stephen R Marder, Nina R Schooler, James M Gold, Robert P McMahon, Uriel Heresco-Levy, and William T Carpenter. 2007. <span>“The Cognitive and Negative Symptoms in Schizophrenia Trial (<span>CONSIST)</span>: The Efficacy of Glutamatergic Agents for Negative Symptoms and Cognitive Impairments.”</span> <em>Am. J. Psychiatry</em> 164 (10): 1593–1602. <a href="https://doi.org/10.1176/appi.ajp.2007.06081358">https://doi.org/10.1176/appi.ajp.2007.06081358</a>.
</div>
<div id="ref-Bustillo2017-cj" class="csl-entry" role="doc-biblioentry">
Bustillo, Juan R, Veena Patel, Thomas Jones, Rex Jung, Nattida Payaknait, Clifford Qualls, Jose M Canive, et al. 2017. <span>“<span>Risk-Conferring</span> Glutamatergic Genes and Brain Glutamate Plus Glutamine in Schizophrenia.”</span> <em>Front. Psychiatry</em> 8 (June): 79. <a href="https://doi.org/10.3389/fpsyt.2017.00079">https://doi.org/10.3389/fpsyt.2017.00079</a>.
</div>
<div id="ref-Dong2009-qx" class="csl-entry" role="doc-biblioentry">
Dong, Xiao-Xia, Yan Wang, and Zheng-Hong Qin. 2009. <span>“Molecular Mechanisms of Excitotoxicity and Their Relevance to Pathogenesis of Neurodegenerative Diseases.”</span> <em>Acta Pharmacol. Sin.</em> 30 (4): 379–87. <a href="https://doi.org/10.1038/aps.2009.24">https://doi.org/10.1038/aps.2009.24</a>.
</div>
<div id="ref-Ellaithy2015-dj" class="csl-entry" role="doc-biblioentry">
Ellaithy, Amr, Jason Younkin, Javier González-Maeso, and Diomedes E Logothetis. 2015. <span>“Positive Allosteric Modulators of Metabotropic Glutamate 2 Receptors in Schizophrenia Treatment.”</span> <em>Trends Neurosci.</em> 38 (8): 506–16. <a href="https://doi.org/10.1016/j.tins.2015.06.002">https://doi.org/10.1016/j.tins.2015.06.002</a>.
</div>
<div id="ref-Fonnum1984-cm" class="csl-entry" role="doc-biblioentry">
Fonnum, F. 1984. <span>“Glutamate: A Neurotransmitter in Mammalian Brain.”</span> <em>J. Neurochem.</em> 42 (1): 1–11. <a href="https://doi.org/10.1111/j.1471-4159.1984.tb09689.x">https://doi.org/10.1111/j.1471-4159.1984.tb09689.x</a>.
</div>
<div id="ref-Fromer2014-ie" class="csl-entry" role="doc-biblioentry">
Fromer, Menachem, Andrew J Pocklington, David H Kavanagh, Hywel J Williams, Sarah Dwyer, Padhraig Gormley, Lyudmila Georgieva, et al. 2014. <span>“De Novo Mutations in Schizophrenia Implicate Synaptic Networks.”</span> <em>Nature</em> 506 (7487): 179–84. <a href="https://doi.org/10.1038/nature12929">https://doi.org/10.1038/nature12929</a>.
</div>
<div id="ref-Gilleen2021-xt" class="csl-entry" role="doc-biblioentry">
Gilleen, James, Judith Nottage, Farah Yakub, Sarah Kerins, Lorena Valdearenas, Tolga Uz, Gez Lahu, et al. 2021. <span>“The Effects of Roflumilast, a Phosphodiesterase Type-4 Inhibitor, on <span>EEG</span> Biomarkers in Schizophrenia: A Randomised Controlled Trial.”</span> <em>J. Psychopharmacol.</em> 35 (1): 15–22. <a href="https://doi.org/10.1177/0269881120946300">https://doi.org/10.1177/0269881120946300</a>.
</div>
<div id="ref-Gulchina2017-wh" class="csl-entry" role="doc-biblioentry">
Gulchina, Yelena, Song-Jun Xu, Melissa A Snyder, Felice Elefant, and Wen-Jun Gao. 2017. <span>“Epigenetic Mechanisms Underlying <span>NMDA</span> Receptor Hypofunction in the Prefrontal Cortex of Juvenile Animals in the <span>MAM</span> Model for Schizophrenia.”</span> <em>J. Neurochem.</em> 143 (3): 320–33. <a href="https://doi.org/10.1111/jnc.14101">https://doi.org/10.1111/jnc.14101</a>.
</div>
<div id="ref-Heckman2018-tz" class="csl-entry" role="doc-biblioentry">
Heckman, P R A, A Blokland, E P P Bollen, and J Prickaerts. 2018. <span>“Phosphodiesterase Inhibition and Modulation of Corticostriatal and Hippocampal Circuits: Clinical Overview and Translational Considerations.”</span> <em>Neurosci. Biobehav. Rev.</em> 87 (April): 233–54. <a href="https://doi.org/10.1016/j.neubiorev.2018.02.007">https://doi.org/10.1016/j.neubiorev.2018.02.007</a>.
</div>
<div id="ref-Heresco-Levy1996-tw" class="csl-entry" role="doc-biblioentry">
Heresco-Levy, U, D C Javitt, M Ermilov, C Mordel, A Horowitz, and D Kelly. 1996. <span>“Double-Blind, Placebo-Controlled, Crossover Trial of Glycine Adjuvant Therapy for Treatment-Resistant Schizophrenia.”</span> <em>Br. J. Psychiatry</em> 169 (5): 610–17. <a href="https://doi.org/10.1192/bjp.169.5.610">https://doi.org/10.1192/bjp.169.5.610</a>.
</div>
<div id="ref-Jadi2016-zz" class="csl-entry" role="doc-biblioentry">
Jadi, Monika P, M Margarita Behrens, and Terrence J Sejnowski. 2016. <span>“Abnormal Gamma Oscillations in <span>N-Methyl-D-Aspartate</span> Receptor Hypofunction Models of Schizophrenia.”</span> <em>Biol. Psychiatry</em> 79 (9): 716–26. <a href="https://doi.org/10.1016/j.biopsych.2015.07.005">https://doi.org/10.1016/j.biopsych.2015.07.005</a>.
</div>
<div id="ref-Javitt1987-xw" class="csl-entry" role="doc-biblioentry">
Javitt, D C. 1987. <span>“Negative Schizophrenic Symptomatology and the <span>PCP</span> (Phencyclidine) Model of Schizophrenia.”</span> <em>Hillside J. Clin. Psychiatry</em> 9 (1): 12–35.
</div>
<div id="ref-Javitt1991-fu" class="csl-entry" role="doc-biblioentry">
Javitt, D C, and S R Zukin. 1991. <span>“Recent Advances in the Phencyclidine Model of Schizophrenia.”</span> <em>Am. J. Psychiatry</em> 148 (10): 1301–8. <a href="https://doi.org/10.1176/ajp.148.10.1301">https://doi.org/10.1176/ajp.148.10.1301</a>.
</div>
<div id="ref-Javitt1994-to" class="csl-entry" role="doc-biblioentry">
Javitt, D C, I Zylberman, S R Zukin, U Heresco-Levy, and J P Lindenmayer. 1994. <span>“Amelioration of Negative Symptoms in Schizophrenia by Glycine.”</span> <em>Am. J. Psychiatry</em> 151 (8): 1234–36. <a href="https://doi.org/10.1176/ajp.151.8.1234">https://doi.org/10.1176/ajp.151.8.1234</a>.
</div>
<div id="ref-Kim1981-mf" class="csl-entry" role="doc-biblioentry">
Kim, J S, H H Kornhuber, U Brand, and H G Menge. 1981. <span>“Effects of Chronic Amphetamine Treatment on the Glutamate Concentration in Cerebrospinal Fluid and Brain: Implications for a Theory of Schizophrenia.”</span> <em>Neurosci. Lett.</em> 24 (1): 93–96. <a href="https://doi.org/10.1016/0304-3940(81)90365-7">https://doi.org/10.1016/0304-3940(81)90365-7</a>.
</div>
<div id="ref-Kim1980-yq" class="csl-entry" role="doc-biblioentry">
Kim, J S, H H Kornhuber, W Schmid-Burgk, and B Holzmüller. 1980. <span>“Low Cerebrospinal Fluid Glutamate in Schizophrenic Patients and a New Hypothesis on Schizophrenia.”</span> <em>Neurosci. Lett.</em> 20 (3): 379–82. <a href="https://doi.org/10.1016/0304-3940(80)90178-0">https://doi.org/10.1016/0304-3940(80)90178-0</a>.
</div>
<div id="ref-Krystal1994-vn" class="csl-entry" role="doc-biblioentry">
Krystal, J H, L P Karper, J P Seibyl, G K Freeman, R Delaney, J D Bremner, G R Heninger, M B Bowers Jr, and D S Charney. 1994. <span>“Subanesthetic Effects of the Noncompetitive <span>NMDA</span> Antagonist, Ketamine, in Humans. Psychotomimetic, Perceptual, Cognitive, and Neuroendocrine Responses.”</span> <em>Arch. Gen. Psychiatry</em> 51 (3): 199–214. <a href="https://doi.org/10.1001/archpsyc.1994.03950030035004">https://doi.org/10.1001/archpsyc.1994.03950030035004</a>.
</div>
<div id="ref-Lahti1995-co" class="csl-entry" role="doc-biblioentry">
Lahti, A C, B Koffel, D LaPorte, and C A Tamminga. 1995. <span>“Subanesthetic Doses of Ketamine Stimulate Psychosis in Schizophrenia.”</span> <em>Neuropsychopharmacology</em> 13 (1): 9–19. <a href="https://doi.org/10.1016/0893-133X(94)00131-I">https://doi.org/10.1016/0893-133X(94)00131-I</a>.
</div>
<div id="ref-Li2001-ck" class="csl-entry" role="doc-biblioentry">
Li, S, and P K Stys. 2001. <span>“<span>Na(+)-K(+)-ATPase</span> Inhibition and Depolarization Induce Glutamate Release via Reverse Na(+)-Dependent Transport in Spinal Cord White Matter.”</span> <em>Neuroscience</em> 107 (4): 675–83. <a href="https://doi.org/10.1016/s0306-4522(01)00385-2">https://doi.org/10.1016/s0306-4522(01)00385-2</a>.
</div>
<div id="ref-Lodge2009-em" class="csl-entry" role="doc-biblioentry">
Lodge, Daniel J, and Anthony A Grace. 2009. <span>“Gestational Methylazoxymethanol Acetate Administration: A Developmental Disruption Model of Schizophrenia.”</span> <em>Behav. Brain Res.</em> 204 (2): 306–12. <a href="https://doi.org/10.1016/j.bbr.2009.01.031">https://doi.org/10.1016/j.bbr.2009.01.031</a>.
</div>
<div id="ref-McQueen2018-ad" class="csl-entry" role="doc-biblioentry">
McQueen, Grant, John Lally, Tracy Collier, Fernando Zelaya, David J Lythgoe, Gareth J Barker, James M Stone, Philip McGuire, James H MacCabe, and Alice Egerton. 2018. <span>“Effects of n-Acetylcysteine on Brain Glutamate Levels and Resting Perfusion in Schizophrenia.”</span> <em>Psychopharmacology</em> 235 (10): 3045–54. <a href="https://doi.org/10.1007/s00213-018-4997-2">https://doi.org/10.1007/s00213-018-4997-2</a>.
</div>
<div id="ref-Merritt2016-bk" class="csl-entry" role="doc-biblioentry">
Merritt, Kate, Alice Egerton, Matthew J Kempton, Matthew J Taylor, and Philip K McGuire. 2016. <span>“Nature of Glutamate Alterations in Schizophrenia: A Meta-Analysis of Proton Magnetic Resonance Spectroscopy Studies.”</span> <em>JAMA Psychiatry</em> 73 (7): 665–74. <a href="https://doi.org/10.1001/jamapsychiatry.2016.0442">https://doi.org/10.1001/jamapsychiatry.2016.0442</a>.
</div>
<div id="ref-Murrie2020-jo" class="csl-entry" role="doc-biblioentry">
Murrie, Benjamin, Julia Lappin, Matthew Large, and Grant Sara. 2020. <span>“Transition of <span>Substance-Induced</span>, Brief, and Atypical Psychoses to Schizophrenia: A Systematic Review and Meta-Analysis.”</span> <em>Schizophr. Bull.</em> 46 (3): 505–16. <a href="https://doi.org/10.1093/schbul/sbz102">https://doi.org/10.1093/schbul/sbz102</a>.
</div>
<div id="ref-Olney1969-vi" class="csl-entry" role="doc-biblioentry">
Olney, J W. 1969. <span>“Brain Lesions, Obesity, and Other Disturbances in Mice Treated with Monosodium Glutamate.”</span> <em>Science</em> 164 (3880): 719–21. <a href="https://doi.org/10.1126/science.164.3880.719">https://doi.org/10.1126/science.164.3880.719</a>.
</div>
<div id="ref-Pina-Crespo2014-by" class="csl-entry" role="doc-biblioentry">
Piña-Crespo, Juan C, Sara Sanz-Blasco, and Stuart A Lipton. 2014. <span>“Concept of Excitotoxicity via Glutamate Receptors.”</span> In <em>Handbook of Neurotoxicity</em>, edited by Richard M Kostrzewa, 1015–38. New York, NY: Springer New York. <a href="https://doi.org/10.1007/978-1-4614-5836-4\_125">https://doi.org/10.1007/978-1-4614-5836-4\_125</a>.
</div>
<div id="ref-Poels2014-wu" class="csl-entry" role="doc-biblioentry">
Poels, Eline M P, Lawrence S Kegeles, Joshua T Kantrowitz, Daniel C Javitt, Jeffrey A Lieberman, Anissa Abi-Dargham, and Ragy R Girgis. 2014. <span>“Glutamatergic Abnormalities in Schizophrenia: A Review of Proton <span>MRS</span> Findings.”</span> <em>Schizophr. Res.</em> 152 (2-3): 325–32. <a href="https://doi.org/10.1016/j.schres.2013.12.013">https://doi.org/10.1016/j.schres.2013.12.013</a>.
</div>
<div id="ref-Potkin1999-mt" class="csl-entry" role="doc-biblioentry">
Potkin, S G, Y Jin, B G Bunney, J Costa, and B Gulasekaram. 1999. <span>“Effect of Clozapine and Adjunctive High-Dose Glycine in Treatment-Resistant Schizophrenia.”</span> <em>Am. J. Psychiatry</em> 156 (1): 145–47. <a href="https://doi.org/10.1176/ajp.156.1.145">https://doi.org/10.1176/ajp.156.1.145</a>.
</div>
<div id="ref-Purcell2014-do" class="csl-entry" role="doc-biblioentry">
Purcell, Shaun M, Jennifer L Moran, Menachem Fromer, Douglas Ruderfer, Nadia Solovieff, Panos Roussos, Colm O’Dushlaine, et al. 2014. <span>“A Polygenic Burden of Rare Disruptive Mutations in Schizophrenia.”</span> <em>Nature</em> 506 (7487): 185–90. <a href="https://doi.org/10.1038/nature12975">https://doi.org/10.1038/nature12975</a>.
</div>
<div id="ref-Schizophrenia_Working_Group_of_the_Psychiatric_Genomics_Consortium2014-ve" class="csl-entry" role="doc-biblioentry">
Schizophrenia Working Group of the Psychiatric Genomics Consortium. 2014. <span>“Biological Insights from 108 Schizophrenia-Associated Genetic Loci.”</span> <em>Nature</em> 511 (7510): 421–27. <a href="https://doi.org/10.1038/nature13595">https://doi.org/10.1038/nature13595</a>.
</div>
<div id="ref-Singh2011-um" class="csl-entry" role="doc-biblioentry">
Singh, Surendra P, and Vidhi Singh. 2011. <span>“Meta-Analysis of the Efficacy of Adjunctive <span>NMDA</span> Receptor Modulators in Chronic Schizophrenia.”</span> <em>CNS Drugs</em> 25 (10): 859–85. <a href="https://doi.org/10.2165/11586650-000000000-00000">https://doi.org/10.2165/11586650-000000000-00000</a>.
</div>
<div id="ref-Snyder2017-rd" class="csl-entry" role="doc-biblioentry">
Snyder, Gretchen L, and Kimberly E Vanover. 2017. <span>“<span>PDE</span> Inhibitors for the Treatment of Schizophrenia.”</span> <em>Adv Neurobiol</em> 17: 385–409. <a href="https://doi.org/10.1007/978-3-319-58811-7\_14">https://doi.org/10.1007/978-3-319-58811-7\_14</a>.
</div>
<div id="ref-Sonnenschein2020-vd" class="csl-entry" role="doc-biblioentry">
Sonnenschein, Susan F, and Anthony A Grace. 2020. <span>“The <span class="nocase">mGluR2/3</span> Agonist Pomaglumetad Methionil Normalizes Aberrant Dopamine Neuron Activity via Action in the Ventral Hippocampus.”</span> <em>Neuropsychopharmacology</em> 45 (12): 2106–13. <a href="https://doi.org/10.1038/s41386-020-0764-2">https://doi.org/10.1038/s41386-020-0764-2</a>.
</div>
<div id="ref-Stavrovskaya2005-lh" class="csl-entry" role="doc-biblioentry">
Stavrovskaya, Irina G, and Bruce S Kristal. 2005. <span>“The Powerhouse Takes Control of the Cell: Is the Mitochondrial Permeability Transition a Viable Therapeutic Target Against Neuronal Dysfunction and Death?”</span> <em>Free Radic. Biol. Med.</em> 38 (6): 687–97. <a href="https://doi.org/10.1016/j.freeradbiomed.2004.11.032">https://doi.org/10.1016/j.freeradbiomed.2004.11.032</a>.
</div>
<div id="ref-Swanson2005-ah" class="csl-entry" role="doc-biblioentry">
Swanson, Chad J, Mark Bures, Michael P Johnson, Anni-Maija Linden, James A Monn, and Darryle D Schoepp. 2005. <span>“Metabotropic Glutamate Receptors as Novel Targets for Anxiety and Stress Disorders.”</span> <em>Nat. Rev. Drug Discov.</em> 4 (2): 131–44. <a href="https://doi.org/10.1038/nrd1630">https://doi.org/10.1038/nrd1630</a>.
</div>
<div id="ref-Uno2019-mx" class="csl-entry" role="doc-biblioentry">
Uno, Yota, and Joseph T Coyle. 2019. <span>“Glutamate Hypothesis in Schizophrenia.”</span> <em>Psychiatry Clin. Neurosci.</em> 73 (5): 204–15. <a href="https://doi.org/10.1111/pcn.12823">https://doi.org/10.1111/pcn.12823</a>.
</div>
<div id="ref-Witt2004-of" class="csl-entry" role="doc-biblioentry">
Witt, Andrea, Nancy Macdonald, and Peter Kirkpatrick. 2004. <span>“Memantine Hydrochloride.”</span> <em>Nat. Rev. Drug Discov.</em> 3 (2): 109–10. <a href="https://doi.org/10.1038/nrd1311">https://doi.org/10.1038/nrd1311</a>.
</div>
<div id="ref-Xing2018-si" class="csl-entry" role="doc-biblioentry">
Xing, Bo, Genie Han, Min-Juan Wang, Melissa A Snyder, and Wen-Jun Gao. 2018. <span>“Juvenile Treatment with <span class="nocase">mGluR2/3</span> Agonist Prevents Schizophrenia-Like Phenotypes in Adult by Acting Through <span>Gsk3β</span>.”</span> <em>Neuropharmacology</em> 137 (July): 359–71. <a href="https://doi.org/10.1016/j.neuropharm.2018.05.019">https://doi.org/10.1016/j.neuropharm.2018.05.019</a>.
</div>
<div id="ref-Yuen2008-sj" class="csl-entry" role="doc-biblioentry">
Yuen, Eunice Y, Qian Jiang, Paul Chen, Jian Feng, and Zhen Yan. 2008. <span>“Activation of <span>5-Ht2a/C</span> Receptors Counteracts <span>5-Ht1a</span> Regulation of n-Methyl-d-Aspartate Receptor Channels in Pyramidal Neurons of Prefrontal Cortex.”</span> <em>J. Biol. Chem.</em> 283 (25): 17194–204. <a href="https://doi.org/10.1074/jbc.M801713200">https://doi.org/10.1074/jbc.M801713200</a>.
</div>
</div>
<!--radix_placeholder_article_footer-->
<!--/radix_placeholder_article_footer-->
</div>

<div class="d-appendix">
</div>


<!--radix_placeholder_site_after_body-->
<!--/radix_placeholder_site_after_body-->
<!--radix_placeholder_appendices-->
<div class="appendix-bottom">
<h3 id="references">References</h3>
<div id="references-listing"></div>
</div>
<!--/radix_placeholder_appendices-->
<!--radix_placeholder_navigation_after_body-->
<!--/radix_placeholder_navigation_after_body-->

</body>

</html>
